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Commentary
 
In addition to the importance of HIV/AIDS sur-
veillance data for tracking and forecasting trends
in the epidemic, data on the number of persons
reported with AIDS are used to target and allo-
cate resources for prevention and treatment ser-
vices. Some of the tables and figures presented
in the 
 
HIV/AIDS Surveillance Report
 
 include
 
counts of cases
 
 (e.g., tables 1-3, 22; figures 3-5)
which represent the number of individuals report-
ed with AIDS or HIV infection.  The number of
cases reported cumulatively or during a recent
time period indicates the size and characteristics
of the populations affected by the epidemic and
the distribution and impact of HIV/AIDS national-
ly. 
Through June 30, 1997, a cumulative total of
612,078 persons with AIDS were reported to
CDC by state and territorial health departments
(table 1). Of these, 84 percent were adult/adoles-
cent men, 15 percent were adult/adolescent
women, and 1 percent were children (under 13
years of age).  Of adults/adolescents reported
during the last 12 months (July 1996–June 1997),
36 percent were white, 43 percent were black,
and 20 percent were Hispanic.  Men who have
sex with men accounted for the largest proportion
of reported cases (38 percent).  Among 609 chil-
dren reported in the last 12 months, 15 percent
were white, 63 percent were black, and 21 per-
cent were Hispanic (table 6).  Over 90 percent of
these children were infected perinatally.  In addi-
tion, 29 states that conduct HIV case surveillance
of adults, adolescents, and/or children reported
86,972 persons who were diagnosed with HIV
(excluding persons tested anonymously) but not
yet diagnosed with AIDS (table 22).  The demo-
graphic and risk/exposure characteristics of re-
ported cases of AIDS and HIV are presented in
tables 1-12 and 22-28.
Many factors affect the number of cases of HIV
or AIDS that will be reported to CDC in any given
time period.  Current and historic HIV transmis-
sion patterns, patterns of HIV testing and access
to care, the impact of therapy on the course of
HIV disease, and variations in surveillance prac-
tices over time or from one jurisdiction to another
are factors that affect the interpretation of surveil-
lance case report data.  
Tables 16-21 and figure 6 have been added to
this edition of the surveillance report to more fully
represent current trends in the epidemic.  In addi-
tion to the estimated numbers of cases diagnosed
with AIDS-defining opportunistic illnesses
(AIDS-OIs) presented in tables 13-15, this report
includes estimated numbers of deaths of persons
reported with AIDS, and estimates of the preva-
lence of AIDS.  CDC has received requests for
data describing trends in AIDS prevalence and
deaths.  These data are of interest as a measure
of the impact of antiretroviral therapy on AIDS
trends.  Because they do not represent actual
counts of persons with AIDS who were reported
to CDC, the estimates are presented as rounded
numbers in the tables. 
In 1996, the estimated number of persons diag-
nosed with an AIDS-OI decreased for the first
time, from 61,300 estimated cases in 1995 to
57,200 in 1996 (tables 13-15).  The actual de-
crease in AIDS-OI incidence is likely to be greater
than the estimated decrease in this report.  The
estimates of AIDS-OI incidence are based on the
estimates of disease progression rates among
persons enrolled in CDC’s Adult/adolescent
Spectrum of Disease Project, but there are not
yet sufficient data to estimate the effects of the
use of recently available antiretroviral treatments.
Also for the first time in 1996, the estimated
deaths among persons with AIDS declined to
39,200 from 50,700 in 1995 (tables 16-18).  The
cumulative number of persons estimated to have
been diagnosed with AIDS based on the 1993
case definition and who have not been reported
as deceased (i.e., the estimated number of prev-
alent AIDS cases or persons who are living with
AIDS), continued to increase, from 215,000 esti-
mated cases in 1995 to 239,000 cases in 1996
(tables 19-21).  
The estimates are derived from models which
adjust surveillance data to account for delays in
reporting cases to CDC and for changes in the
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AIDS case definition over time.  Estimates of
AIDS incidence and deaths are not adjusted for
incomplete reporting.   To illustrate how these es-
timates are used to monitor trends, figure 6 pre-
sents three estimated incidence curves.  The top
curve represents the number of cases diagnosed
with AIDS using the 1993 definition criteria after
adjustments for reporting delays.  It represents
the distribution of all cases diagnosed with AIDS
and illustrates the distorting effect of the change
in the case definition.  The middle curve repre-
sents the estimated number of cases diagnosed
with AIDS-OIs and accounts for the change in
case definition and reporting delays.  It shows the
gradual slowing in the growth of the epidemic dur-
ing the mid-1990's and the recent decline in
AIDS-OI incidence using consistent diagnostic
criteria over time.  The bottom curve represents
the reported number of deaths of persons with
AIDS using the 1993 case definition after adjust-
ments for reporting delays.  It shows the substan-
tial recent decline in deaths of persons with AIDS.
The convergence of the top and middle curves in
figure 6 illustrates that the temporary distorting ef-
fect that the expansion of the AIDS surveillance
case definition had on temporal trends has
waned.  In the near future, it will no longer be nec-
essary to adjust for the effect of the 1993 expand-
ed case definition when presenting estimated
numbers of AIDS cases diagnosed in a given
year or when  comparing trends in diagnoses
over time, from approximately 1996 forward.                   
The estimation procedures and the sources of
data included in the models are described in the
Technical Notes of this report.  Because the anal-
ysis and interpretation of surveillance data re-
quire an understanding of how the data are
collected, reported, and analyzed, as well as their
uses and limitations, readers of this report are en-
couraged to review the Technical Notes and con-
sult the references listed under Suggested
Reading. 
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Table 1. AIDS cases and annual rates per 100,000 population, by state, reported July 1995
through June 1996, 
 
 
 
July 1996 through June 1997; and cumulative totals, by state
and age group, through June 1997, United States
 
July 1995–
June 1996
July 1996–
June 1997 Cumulative totals
State of residence No. Rate No. Rate
Adults/
adolescents
Children 
< 13 years old Total 
 
Alabama 664 15.6 521 12.2 4,441 63 4,504
Alaska 37 6.1 44 7.2 380 5 385
Arizona 656 15.2 532 12.0 5,237 21 5,258
Arkansas 285 11.5 243 9.7 2,238 32 2,270
California 10,540 33.4 8,177 25.7 101,020 549 101,569
Colorado 597 15.9 432 11.3 5,935 27 5,962
Connecticut 1,518 46.4 1,198 36.6 9,002 172 9,174
Delaware 319 44.5 264 36.4 1,908 14 1,922
District of Columbia 1,049 189.2 1,196 220.2 9,799 147 9,946
Florida 7,686 54.2 6,725 46.7 60,930 1,270 62,200
Georgia 2,495 34.6 2,108 28.7 17,808 177 17,985
Hawaii 207 17.6 144 12.2 2,014 14 2,028
Idaho 45 3.9 44 3.7 392 2 394
Illinois 2,148 18.2 1,753 14.8 19,095 224 19,319
Indiana 653 11.3 564 9.7 4,746 33 4,779
Iowa 129 4.5 105 3.7 1,020 8 1,028
Kansas 256 10.0 189 7.3 1,909 10 1,919
Kentucky 314 8.1 405 10.4 2,380 21 2,401
Louisiana 1,361 31.4 1,232 28.3 9,548 112 9,660
Maine 80 6.5 55 4.4 774 9 783
Maryland 2,287 45.4 2,175 42.9 15,955 268 16,223
Massachusetts 1,294 21.3 1,126 18.5 12,331 192 12,523
Michigan 1,032 10.8 949 9.9 8,681 89 8,770
Minnesota 322 7.0 248 5.3 3,075 20 3,095
Mississippi 414 15.4 448 16.5 3,006 44 3,050
Missouri 845 15.9 691 12.9 7,437 50 7,487
Montana 30 3.4 42 4.8 246 3 249
Nebraska 98 6.0 99 6.0 834 9 843
Nevada 457 29.8 466 29.1 3,275 25 3,300
New Hampshire 99 8.6 68 5.8 721 8 729
New Jersey 3,981 50.1 3,777 47.3 34,178 693 34,871
New Mexico 113 6.7 229 13.4 1,517 5 1,522
New York 13,242 72.8 12,525 68.9 111,541 2,008 113,549
North Carolina 977 13.6 859 11.7 7,637 105 7,742
North Dakota 10 1.6 10 1.6 85 – 85
Ohio 1,107 9.9 930 8.3 9,001 108 9,109
Oklahoma 279 8.5 288 8.7 2,861 25 2,886
Oregon 500 15.9 357 11.1 4,007 14 4,021
Pennsylvania 2,266 18.8 2,127 17.6 18,136 252 18,388
Rhode Island 181 18.3 162 16.4 1,652 16 1,668
South Carolina 967 26.4 815 22.0 6,592 69 6,661
South Dakota 17 2.3 10 1.4 118 4 122
Tennessee 901 17.2 796 15.0 5,901 46 5,947
Texas 4,375 23.3 4,928 25.8 41,863 322 42,185
Utah 197 10.1 159 7.9 1,429 20 1,449
Vermont 40 6.8 32 5.4 313 3 316
Virginia 1,506 22.8 1,255 18.8 9,548 151 9,699
Washington 773 14.2 764 13.8 7,898 32 7,930
West Virginia 147 8.1 113 6.2 793 8 801
Wisconsin 326 6.4 253 4.9 2,892 24 2,916
Wyoming 14 2.9 17 3.5 151 2 153
 
Subtotal 69,836 26.6 62,649 23.6 584,250 7,525 591,775
U.S. dependencies, possessions, and associated nations
 
Guam 4 2.8 2 1.4 19 – 19
Pacific Islands, U.S. – – 2 0.7 4 – 4
Puerto Rico 2,135 56.9 2,210 58.4 19,220 363 19,583
Virgin Islands, U.S. 32 30.6 56 53.4 317 13 330
 
Total
 
1
 
72,085 27.0 64,966 24.1 604,176 7,902 612,078
 
1
 
U.S. totals presented in this report include data from the United States (50 states and the District of Columbia), and from U.S. dependencies, possessions, and
independent nations in free association with the United States. See Technical Notes.  Totals include 367 persons whose state of residence is unknown.
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Table 2. AIDS cases and annual rates per 100,000 population, by metropolitan area with
500,000 or more population, reported July 1995 through June 1996, July 1996
through June 1997; and cumulative totals, by area and age group, through 
June 1997, United States 
 
July 1995–
June 1996
July 1996–
June 1997 Cumulative totals 
Metropolitan area of residence No. Rate No. Rate
Adults/
adolescents
Children 
<13 years old Total 
 
Akron, Ohio 33 4.9 75 11.0 418 – 418
Albany-Schenectady, N.Y. 210 23.8 193 22.0 1,340 20 1,360
Albuquerque, N.Mex. 53 8.0 135 20.1 838 2 840
Allentown, Pa. 105 17.1 78 12.7 629 8 637
Ann Arbor, Mich. 38 7.3 24 4.5 304 7 311
Atlanta, Ga. 1,768 51.4 1,416 40.0 12,734 93 12,827
Austin, Tex. 293 29.1 276 26.5 3,041 19 3,060
Bakersfield, Calif. 167 27.1 66 10.6 738 4 742
Baltimore, Md. 1,516 61.4 1,529 61.8 10,583 186 10,769
Baton Rouge, La. 221 39.2 273 48.1 1,279 18 1,297
Bergen-Passaic, N.J. 490 37.5 520 39.7 4,489 69 4,558
Birmingham, Ala. 211 23.7 156 17.4 1,385 19 1,404
Boston, Mass. 1,129 19.6 952 16.4 10,895 168 11,063
Buffalo, N.Y. 46 3.9 385 32.8 1,273 15 1,288
Charlotte, N.C. 198 15.3 156 11.8 1,538 19 1,557
Chicago, Ill. 1,809 23.5 1,437 18.6 16,544 199 16,743
Cincinnati, Ohio 272 17.1 117 7.3 1,532 14 1,546
Cleveland, Ohio 246 11.0 277 12.4 2,613 36 2,649
Columbus, Ohio 192 13.4 176 12.2 1,857 12 1,869
Dallas, Tex. 1,007 33.8 904 29.7 10,017 35 10,052
Dayton, Ohio 116 12.2 91 9.6 808 15 823
Denver, Colo. 447 24.4 327 17.5 4,767 19 4,786
Detroit, Mich. 724 16.8 578 13.4 5,984 64 6,048
El Paso, Tex. 120 17.7 114 16.7 715 2 717
Fort Lauderdale, Fla. 1,221 86.4 1,127 78.4 9,713 224 9,937
Fort Worth, Tex. 199 13.3 310 20.3 2,580 25 2,605
Fresno, Calif. 145 17.1 89 10.3 953 13 966
Gary, Ind. 67 10.8 87 14.0 553 3 556
Grand Rapids, Mich. 85 8.5 69 6.8 608 3 611
Greensboro, N.C. 177 15.7 102 8.9 1,246 19 1,265
Greenville, S.C. 138 15.6 124 13.8 1,081 2 1,083
Harrisburg, Pa. 93 15.2 104 16.9 683 5 688
Hartford, Conn. 511 46.0 412 37.1 3,065 46 3,111
Honolulu, Hawaii 141 16.2 95 10.9 1,468 11 1,479
Houston, Tex. 1,332 35.8 1,806 47.6 14,988 136 15,124
Indianapolis, Ind. 332 22.5 229 15.3 2,285 13 2,298
Jacksonville, Fla. 386 39.3 367 36.4 3,458 65 3,523
Jersey City, N.J. 631 114.5 605 109.8 5,528 113 5,641
Kansas City, Mo. 342 20.4 228 13.5 3,302 12 3,314
Knoxville, Tenn. 65 10.1 65 10.0 529 6 535
Las Vegas, Nev. 374 32.7 382 31.8 2,597 24 2,621
Little Rock, Ark. 86 15.8 96 17.5 821 10 831
Los Angeles, Calif. 3,889 42.8 3,232 35.4 35,753 221 35,974
Louisville, Ky. 150 15.2 248 25.0 1,128 14 1,142
Memphis, Tenn. 302 28.3 290 26.9 2,103 15 2,118
Miami, Fla. 2,356 115.1 1,799 86.6 18,757 448 19,205
Middlesex, N.J. 330 30.6 261 23.9 2,652 66 2,718
Milwaukee, Wis. 162 11.1 151 10.4 1,573 14 1,587
Minneapolis-Saint Paul, Minn. 278 10.2 220 8.0 2,720 16 2,736
Mobile, Ala. 109 21.2 84 16.2 855 11 866
Monmouth-Ocean, N.J. 288 27.4 236 22.2 2,380 59 2,439
Nashville, Tenn. 293 26.8 272 24.3 1,867 16 1,883
Nassau-Suffolk, N.Y. 639 24.1 664 25.0 5,395 83 5,478
New Haven, Conn. 855 52.6 670 41.1 5,160 120 5,280
New Orleans, La. 730 55.5 640 48.7 5,461 56 5,517
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New York, N.Y. 11,303 131.0 10,129 117.2 95,275 1,828 97,103
Newark, N.J. 1,525 78.7 1,552 80.0 13,729 297 14,026
Norfolk, Va. 545 35.5 492 31.9 2,676 57 2,733
Oakland, Calif. 663 30.2 548 24.8 6,787 39 6,826
Oklahoma City, Okla. 117 11.5 153 14.9 1,331 7 1,338
Omaha, Nebr. 64 9.5 72 10.6 588 3 591
Orange County, Calif. 514 19.8 358 13.6 4,636 27 4,663
Orlando, Fla. 589 42.5 495 34.9 4,387 68 4,455
Philadelphia, Pa. 1,697 34.3 1,589 32.1 13,908 211 14,119
Phoenix, Ariz. 462 17.4 333 12.1 3,698 12 3,710
Pittsburgh, Pa. 227 9.5 179 7.5 1,996 16 2,012
Portland, Oreg. 354 20.6 269 15.3 3,270 8 3,278
Providence, R.I. 167 18.4 154 17.0 1,548 15 1,563
Raleigh-Durham, N.C. 173 17.4 152 14.8 1,528 21 1,549
Richmond, Va. 279 30.1 246 26.3 1,946 25 1,971
Riverside-San Bernardino, Calif. 658 22.2 562 18.6 5,423 47 5,470
Rochester, N.Y. 323 29.7 302 27.8 1,741 11 1,752
Sacramento, Calif. 277 19.0 213 14.4 2,611 24 2,635
Saint Louis, Mo. 436 17.2 418 16.4 3,766 31 3,797
Salt Lake City, Utah 175 14.6 141 11.6 1,257 14 1,271
San Antonio, Tex. 374 25.6 369 24.8 3,166 26 3,192
San Diego, Calif. 1,140 43.4 810 30.5 8,689 49 8,738
San Francisco, Calif. 1,785 108.5 1,376 83.1 24,748 37 24,785
San Jose, Calif. 296 18.8 217 13.6 2,662 13 2,675
San Juan, P.R. 1,300 66.3 1,381 70.2 12,048 228 12,276
Sarasota, Fla. 122 23.2 108 20.4 1,102 21 1,123
Scranton, Pa. 32 5.1 39 6.2 337 4 341
Seattle, Wash. 540 24.5 496 22.2 5,689 18 5,707
Springfield, Mass. 169 28.5 157 26.5 1,288 23 1,311
Stockton, Calif. 81 15.4 64 12.0 592 13 605
Syracuse, N.Y. 78 10.4 182 24.4 952 7 959
Tacoma, Wash. 69 10.6 62 9.4 636 8 644
Tampa-Saint Petersburg, Fla. 752 34.5 656 29.8 6,485 85 6,570
Toledo, Ohio 65 10.6 56 9.2 468 10 478
Tucson, Ariz. 144 19.1 141 18.4 1,145 6 1,151
Tulsa, Okla. 90 12.0 83 11.0 872 8 880
Ventura, Calif. 89 12.6 68 9.5 665 2 667
Washington, D.C. 2,066 45.8 2,019 44.2 17,426 252 17,678
West Palm Beach, Fla. 833 85.3 725 73.0 5,694 186 5,880
Wichita, Kans. 78 15.3 61 11.9 562 2 564
Wilmington, Del. 272 49.8 216 39.2 1,526 9 1,535
Youngstown, Ohio 29 4.8 27 4.5 264 – 264
 
Metropolitan areas with 500,000 
or more population 59,069 36.0 52,989 32.0 506,700 6,680 513,380
 
Central counties 57,848 38.7 51,785 34.3 497,218 6,560 503,778
Outlying counties 1,221 8.5 1,204 8.2 9,482 120 9,602
 
Metropolitan areas with 50,000 
to 500,000 population 7,825 16.0 7,160 14.5 61,181 758 61,939
 
Central counties 7,345 16.8 6,694 15.2 57,450 694 58,144
Outlying counties 480 9.0 466 8.6 3,731 64 3,795
 
Nonmetropolitan areas 4,696 8.7 4,353 8.0 33,634 444 34,078
Total
 
1
 
72,085 27.0 64,966 24.1 604,176 7,902 612,078
 
1
 
Totals include 2,681 persons whose area of residence is unknown.
 
Table 2. AIDS cases and annual rates per 100,000 population, by metropolitan area with
500,000 or more population, reported July 1995 through June 1996, July 1996
through June 1997; and cumulative totals, by area and age group, through 
June 1997, United States — Continued
 
July 1995–
June 1996
July 1996–
June 1997 Cumulative totals 
Metropolitan area of residence No. Rate No. Rate
Adults/
adolescents
Children 
<13 years old Total 
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Table 3. AIDS cases by age group, exposure category, and sex, reported July 1995 through
June 1996, July 1996 through June 1997; and cumulative totals, by age group and
exposure category, through June 1997, United States
 
Males Females Totals
July 1995–
June 1996
July 1996–
June 1997
July 1995–
June 1996
July 1996–
June 1997
July 1995–
June 1996
July 1996–
June 1997
Cumulative
total
 
1
 
Adult/adolescent 
exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
 
Men who have sex with men 29,773 (52) 24,146 (48) – – – – 29,773 (42) 24,146 (38) 298,699 (49)
Injecting drug use 13,701 (24) 11,576 (23) 5,219 (37) 4,574 (33) 18,920 (27) 16,150 (25) 154,664 (26)
Men who have sex with men 
and inject drugs 3,528 ( 6) 2,684 ( 5) – – – – 3,528 ( 5) 2,684 ( 4) 38,923 ( 6)
Hemophilia/coagulation disorder 366 ( 1) 250 ( 0) 27 ( 0) 15 ( 0) 393 ( 1) 265 ( 0) 4,567 ( 1)
Heterosexual contact: 3,249 ( 6) 3,357 ( 7) 5,940 (43) 5,459 (40) 9,189 (13) 8,816 (14) 54,571 ( 9)
 
Sex with injecting drug user 969 794 2,078 1,666 3,047 2,460 22,890
Sex with bisexual male – – 400 298 400 298 2,768
Sex with person with hemophilia 11 5 37 36 48 41 390
Sex with transfusion recipient 
with HIV infection 37 33 69 40 106 73 867
Sex with HIV-infected person, 
risk not specified 2,232 2,525 3,356 3,419 5,588 5,944 27,656
 
Receipt of blood transfusion, 
blood components, or tissue
 
2
 
323 ( 1) 245 ( 0) 274 ( 2) 244 ( 2) 597 ( 1) 489 ( 1) 8,075 ( 1)
Other/risk not reported
 or identified
 
3
 
6,497 (11) 8,385 (17) 2,479 (18) 3,422 (25) 8,976 (13) 11,807 (18) 44,677 ( 7)
Adult/adolescent subtotal 57,437 (100) 50,643 (100) 13,939 (100) 13,714 (100) 71,376 (100) 64,357 (100) 604,176 (100)
 
Pediatric (<13 years old) 
exposure category 
 
Hemophilia/coagulation disorder 2 ( 1) 3 ( 1) – – 1 ( 0) 2 ( 0) 4 ( 1) 232 ( 3)
Mother with/at risk for HIV infection
 
3
 
331 (93) 291 (91) 335 (95) 261 (90) 666 (94) 552 (91) 7,157 (91)
 
Injecting drug use 96 79 92 61 188 140 2,878
Sex with an injecting drug user 55 36 44 36 99 72 1,304
Sex with a bisexual male 4 7 7 4 11 11 161
Sex with person with hemophilia – 2 1 – 1 2 27
Sex with transfusion recipient 
with HIV infection – – – – – – 26
Sex with HIV-infected person, 
risk not specified 60 59 62 58 122 117 982
Receipt of blood transfusion, 
blood components, or tissue 2 5 1 5 3 10 150
Has HIV infection, risk not 
specified 114 103 128 97 242 200 1,629
 
Receipt of blood transfusion, 
blood components, or tissue
 
2
 
10 ( 3) 2 ( 1) 2 ( 1) 3 ( 1) 12 ( 2) 5 ( 1) 375 ( 5)
Risk not reported or identified
 
3
 
13 ( 4) 24 ( 8) 16 ( 5) 24 ( 8) 29 ( 4) 48 ( 8) 138 ( 2)
Pediatric subtotal 356 (100) 320 (100) 353 (100) 289 (100) 709 (100) 609 (100) 7,902 (100)
 
Total 57,793 50,963 14,292 14,003 72,085 64,966 612,078
 
1
 
Includes 11 persons known to be infected with human immunodeficiency virus type 2 (HIV-2). See 
 
MMWR
 
 1995;44:603-06.
 
2
 
Thirty-seven adults/adolescents and 3 children developed AIDS after receiving blood screened negative for HIV antibody. Twelve additional adults developed
AIDS after receiving tissue, organs, or artificial insemination from HIV-infected donors. Four of the 12 received tissue, organs, or artificial insemination from a
donor who was negative for HIV antibody at the time of donation. See 
 
N Engl J Med
 
 1992;326:726-32.
 
3
 
See table 11 and figure 7 for a discussion of the "other" exposure category. "Other" also includes 63 persons who acquired HIV infection perinatally but were
diagnosed with AIDS after age 13.  These 63 persons are tabulated under the adult/adolescent, not pediatric, exposure category.
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Table 4. Male adult/adolescent AIDS cases by exposure category and race/ethnicity, 
reported July 1996 through June 1997, and cumulative totals, through June 1997,
United States
 
White, not Hispanic Black, not Hispanic Hispanic 
July 1996–
June 1997
Cumulative 
total
July 1996–
June 1997
Cumulative 
total
July 1996–
June 1997
Cumulative 
total
Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) 
 
Men who have sex with men 13,805 (68) 194,042 (76) 6,251 (32) 61,894 (38) 3,675 (37) 38,765 (44)
Injecting drug use 2,302 (11) 22,962 ( 9) 5,984 (31) 57,409 (36) 3,198 (32) 32,724 (37)
Men who have sex with men 
and inject drugs 1,309 ( 6) 20,385 ( 8) 951 ( 5) 12,246 ( 8) 391
( 4)
5,915 ( 7)
Hemophilia/coagulation disorder 181 ( 1) 3,442 ( 1) 36 ( 0) 466 ( 0) 26 ( 0) 376 ( 0)
Heterosexual contact: 585 ( 3) 3,881 ( 2) 1,883 (10) 10,511 ( 7) 841  ( 8) 4,263 ( 5)
 
Sex with an injecting drug user 151 1,505 451 4,036 182 1,323
Sex with person with hemophilia 1 24 3 12 1 8
Sex with transfusion recipient
with HIV infection 14 138 14 120 5 75
Sex with HIV-infected person, 
risk not specified 419 2,214 1,415 6,343 653 2,857
 
Receipt of blood tranfusion, 
blood components, or tissue 119 ( 1) 3,043 ( 1) 81 ( 0) 960 ( 1) 39 ( 0) 516 ( 1)
Risk not reported or identified
 
1
 
2,026 (10) 8,598 ( 3) 4,425 (23) 17,498 (11) 1,738 (18) 6,197 ( 7)
 
Total 20,327 (100) 256,353 (100) 19,611 (100) 160,984 (100) 9,908 (100) 88,756 (100)
Asian/Pacific Islander American Indian/Alaska Native Cumulative totals
 
2
 
July 1996–
June 1997
Cumulative 
total
July 1996–
June 1997
Cumulative 
total
July 1996–
June 1997
Cumulative 
total
Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) 
 
Men who have sex with men 267 (60) 2,884 (75) 91 (51) 822 (59) 24,146 (48) 298,699 (58)
Injecting drug use 23 ( 5) 203 ( 5) 34 (19) 210 (15) 11,576 (23) 113,635 (22)
Men who have sex with men and
 inject drugs 9 ( 2) 128 ( 3) 22 (12) 231 (17) 2,684
( 5)
38,923 ( 8)
Hemophilia/coagulation disorder 4 ( 1) 61 ( 2) 2 ( 1) 27 ( 2) 250 ( 0) 4,378 ( 1)
Heterosexual contact: 32 ( 7) 111 ( 3) 8 ( 4) 28 ( 2) 3,357 ( 7) 18,811 ( 4)
 
Sex with an injecting drug user 6 27 3 12 794 6,906
Sex with person with hemophilia – – – – 5 44
Sex with transfusion recipient 
with HIV infection – 7 – 1 33 342
Sex with HIV-infected person, 
risk not specified 26 77 5 15 2,525 11,519
 
Receipt of blood tranfusion, 
blood components, or tissue 3 ( 1) 98 ( 3) 2 ( 1) 7 ( 1) 245 ( 0) 4,634 ( 1)
Risk not reported or identified 106 (24) 365 ( 9) 20 (11) 65 ( 5) 8,385 (17) 32,854 ( 6)
 
Total 444 (100) 3,850 (100) 179 (100) 1,390 (100) 50,643 (100) 511,934 (100)
 
1
 
See figure 7.
 
2
 
Includes 601 men whose race/ethnicity is unknown.
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Table 5. Female adult/adolescent AIDS cases by exposure category and race/ethnicity, 
reported July 1996 through June 1997, and cumulative totals, through June 1997,
United States
 
White, not Hispanic Black, not Hispanic Hispanic 
July 1996–
June 1997
Cumulative 
total
July 1996–
June 1997
Cumulative 
total
July 1996–
June 1997
Cumulative 
total 
Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) 
 
Injecting drug use 1,039 (38) 9,156 (43) 2,627 (32) 23,646 (46) 866 (33) 7,984 (43)
Hemophilia/coagulation disorder 2 ( 0) 89 ( 0) 8 ( 0) 63 ( 0) 3 ( 0) 32 ( 0)
Heterosexual contact: 1,082 (40) 8,338 (39) 3,080 (38) 18,482 (36) 1,236 (47) 8,596 (46)
 
Sex with injecting drug user 375 3,567 880 7,961 399 4,335
Sex with bisexual male 102 1,224 136 1,043 48 426
Sex with person with hemophilia 19 250 12 59 4 30
Sex with transfusion recipient 
with HIV infection 15 275 17 142 7 91
Sex with HIV-infected person, 
risk not specified 571 3,022 2,035 9,277 778 3,714
 
Receipt of blood transfusion, 
blood components, or tissue 73 ( 3) 1,733 ( 8) 126 ( 2) 1,098 ( 2) 37 ( 1) 508 ( 3)
Risk not reported or identified
 
1
 
526 (19) 2,003 ( 9) 2,321 (28) 8,121 (16) 511 (19) 1,543 ( 8)
 
Total 2,722 (100) 21,319 (100) 8,162 (100) 51,410 (100) 2,653 (100) 18,663 (100)
Asian/Pacific Islander American Indian/Alaska Native Cumulative totals
 
2
 
July 1996–
June 1997
Cumulative 
total
July 1996–
June 1997
Cumulative 
total
July 1996–
June 1997
Cumulative 
total 
Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) 
 
Injecting drug use 9 (11) 80 (17) 18 (45) 124 (48) 4,574 (33) 41,029 (44)
Hemophilia/coagulation disorder 1 ( 1) 4 ( 1) 1 ( 3) 1 ( 0) 15 ( 0) 189 ( 0)
Heterosexual contact: 36 (44) 219 (46) 12 (30) 95 (36) 5,459 (40) 35,760 (39)
 
Sex with injecting drug user 8 63 3 49 1,666 15,984
Sex with bisexual male 5 54 3 15 298 2,768
Sex with person with hemophilia 1 5 – 2 36 346
Sex with transfusion recipient 
with HIV infection 1 16 – – 40 525
Sex with HIV-infected person, 
risk not specified 21 81 6 29 3,419 16,137
 
Receipt of blood transfusion, 
blood components, or tissue 6 ( 7) 87 (18) 1 ( 3) 12 ( 5) 244 ( 2) 3,441 ( 4)
Risk not reported or identified 30 (37) 89 (19) 8 (20) 29 (11) 3,422 (25) 11,823 (13)
 
Total 82 (100) 479 (100) 40 (100) 261 (100) 13,714 (100) 92,242 (100)
 
1
 
See figure 7. 
 
2
 
Includes 110 women whose race/ethnicity is unknown.
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Table 6. Pediatric AIDS cases by exposure category and race/ethnicity, reported July 1996
through June 1997, and cumulative totals, through June 1997, United States
 
White, not Hispanic Black, not Hispanic Hispanic
July 1996–
June 1997
Cumulative 
total
July 1996–
June 1997
Cumulative 
total
July 1996–
June 1997
Cumulative 
total 
Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
 
Hemophilia/coagulation disorder 2 ( 2) 157 (11) 1 ( 0) 34 ( 1) 1 ( 1) 37 ( 2)
Mother with/at risk for HIV infection: 81 (90) 1,037 (74) 345 (90) 4,374 (95) 121 (93) 1,679 (92)
 
Injecting drug use 20 433 88 1,740 32 685
Sex with injecting drug user 10 199 42 648 16 444
Sex with bisexual male 7 65 3 56 1 38
Sex with person with hemophilia 1 16 – 5 1 6
Sex with transfusion recipient 
with HIV infection – 11 – 8 – 7
Sex with HIV-infected person, 
risk not specified 19 121 69 634 29 214
Receipt of blood transfusion, 
blood components, or tissue 4 42 3 76 3 31
Has HIV infection, risk not specified 20 150 140 1,207 39 254
 
Receipt of blood transfusion, blood 
components, or tissue 1 ( 1) 183 (13) 3 ( 1) 90 ( 2) 1 ( 1) 92 ( 5)
Risk not reported or identified
 
1
 
6 ( 7) 23 ( 2) 34 ( 9) 88 ( 2) 7 ( 5) 25 ( 1)
 
Total 90 (100) 1,400 (100) 383 (100) 4,586 (100) 130 (100) 1,833 (100)
Asian/Pacific Islander American Indian/Alaska Native Cumulative totals
 
2
 
July 1996–
June 1997
Cumulative 
total
July 1996–
June 1997
Cumulative 
total
July 1996–
June 1997
Cumulative 
total 
Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
 
Hemophilia/coagulation disorder – – 3 ( 7) – – 1 ( 4) 4 ( 1) 232 ( 3)
Mother with/at risk for HIV infection: – – 27 (66) 4 (100) 25 (96) 552 (91) 7,157 (91)
 
Injecting drug use – 4 – 11 140 2,878
Sex with injecting drug user – 4 4 8 72 1,304
Sex with bisexual male – 2 – – 11 161
Sex with person with hemophilia – – – – 2 27
Sex with transfusion recipient 
with HIV infection
–
– – – – 26
Sex with HIV-infected person, 
risk not specified
–
8 – 2 117 982
Receipt of blood transfusion, 
blood components, or tissue
–
1 – – 10 150
Has HIV infection, risk not specified – 8 – 4 200 1,629
 
Receipt of blood transfusion, blood
components, or tissue
– –
10 (24) – – – – 5 ( 1) 375 ( 5)
Risk not reported or identified – – 1 ( 2) – – – – 48 ( 8) 138 ( 2)
 
Total – – 41 (100) 4 (100) 26 (100) 609 (100) 7,902 (100)
 
1
 
See figure 7, footnote 1.
 
2
 
Includes 16 children whose race/ethnicity is unknown.
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Table 7. AIDS cases in adolescents and adults under age 25, by sex and exposure 
category, reported July 1995 through June 1996, July 1996 through June 1997; 
and cumulative totals through June 1997, United States
 
13-19 years old 20-24 years old 
July 1995–
June 1996
July 1996–
June 1997
Cumulative 
total
July 1995–
June 1996
July 1996–
June 1997
Cumulative 
total 
Male exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) 
 
Men who have sex with men 68 (34) 85 (39) 629 (34) 874 (59) 750 (57) 10,259 (63)
Injecting drug use 11 ( 5) 8 ( 4) 114 ( 6) 185 (12) 123 ( 9) 2,038 (12)
Men who have sex with men 
and inject drugs 6 ( 3) 5 ( 2) 83 ( 4) 100 ( 7) 67 ( 5) 1,717 (11)
Hemophilia/coagulation disorder 63 (31) 38 (17) 713 (38) 69 ( 5) 31 ( 2) 599 ( 4)
Heterosexual contact: 11 ( 5) 15 ( 7) 62 ( 3) 95 ( 6) 99 ( 8) 655 ( 4)
 
Sex with injecting drug user 3 1 17 17 17 230
Sex with person with hemophilia – – 2 3 – 4
Sex with transfusion recipient 
with HIV infection – 1 1 – – 11
Sex with HIV-infected person, 
risk not specified 8 13 42 75 82 410
 
Receipt of blood transfusion,
blood components, or tissue
8 ( 4) 11 ( 5) 80 ( 4) 6 ( 0) 5 ( 0) 103 ( 1)
Risk not reported or identified
 
1
 
35 (17) 56 (26) 171 ( 9) 159 (11) 234 (18) 979 ( 6)
Male subtotal 202 (100) 218 (100) 1,852 (100) 1,488 (100) 1,309 (100) 16,350 (100)
 
Female exposure category 
 
Injecting drug use 12 ( 7) 15 ( 9) 164 (15) 146 (18) 118 (15) 1,650 (29)
Hemophilia/coagulation disorder – – – – 10 ( 1) 2 ( 0) 1 ( 0) 14 ( 0)
Heterosexual contact: 100 (56) 71 (41) 590 (54) 445 (56) 439 (56) 3,067 (54)
 
Sex with injecting drug user 23 16 229 139 101 1,337
Sex with bisexual male 4 6 34 29 22 226
Sex with person with hemophilia 1 – 13 4 3 49
Sex with transfusion recipient 
with HIV infection – 1 2 6 2 21
Sex with HIV-infected person, 
risk not specified 72 48  312 267 311 1,434
 
Receipt of blood transfusion, 
blood components, or tissue 7 ( 4) 10 ( 6) 76 ( 7) 9 ( 1) 7 ( 1) 112 ( 2)
Risk not reported or identified 59 (33) 76 (44) 261 (24) 192 (24) 222 (28) 877 (15)
Female subtotal 178 (100) 172 (100) 1,101 (100) 794 (100) 787 (100) 5,720 (100)
 
Total 380 390 2,953 2,282 2,096 22,070
 
1
 
See figure 7.
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Table 8. AIDS cases by sex, age at diagnosis, and race/ethnicity, reported through 
June 1997, United States
 
Male
Age at diagnosis (years)
White, 
not Hispanic
Black, 
not Hispanic Hispanic
Asian/Pacific 
Islander
American Indian/
Alaska Native Total
 
1
 
No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
 
Under 5 480 ( 0) 1,911 ( 1) 703 ( 1) 15 ( 0) 11 ( 1) 3,124 ( 1)
5-12 310 ( 0) 378 ( 0) 245 ( 0) 8 ( 0) 2 ( 0) 945 ( 0)
13-19 773 ( 0) 653 ( 0) 386 ( 0) 21 ( 1) 17 ( 1) 1,852 ( 0)
20-24 6,929 ( 3) 5,746 ( 4) 3,458 ( 4) 131 ( 3) 63 ( 4) 16,350 ( 3)
25-29 34,486 (13) 21,058 (13) 13,613 (15) 474 (12) 269 (19) 69,978 (14)
30-34 60,527 (24) 34,920 (21) 21,615 (24) 865 (22) 374 (27) 118,424 (23)
35-39 57,986 (23) 37,336 (23) 19,989 (22) 844 (22) 304 (22) 116,601 (23)
40-44 42,054 (16) 28,422 (17) 13,800 (15) 683 (18) 204 (15) 85,274 (17)
45-49 25,152 (10) 15,671 (10) 7,580 ( 8) 388 (10) 83 ( 6) 48,928 ( 9)
50-54 13,461 ( 5) 8,142 ( 5) 3,936 ( 4) 211 ( 5) 32 ( 2) 25,815 ( 5)
55-59 7,378 ( 3) 4,566 ( 3) 2,217 ( 2) 126 ( 3) 23 ( 2) 14,330 ( 3)
60-64 4,162 ( 2) 2,487 ( 2) 1,215 ( 1) 55 ( 1) 13 ( 1) 7,942 ( 2)
65 or older 3,445 ( 1) 1,983 ( 1) 947 ( 1) 52 ( 1) 8 ( 1) 6,440 ( 1)
Male subtotal 257,143 (100) 163,273 (100) 89,704 (100) 3,873 (100) 1,403 (100) 516,003 (100)
 
Female
Age at diagnosis (years)
 
Under 5 458 ( 2) 1,907 ( 4) 700 ( 4) 11 ( 2) 13 ( 5) 3,097 ( 3)
5-12 152 ( 1) 390 ( 1) 185 ( 1) 7 ( 1) – – 736 ( 1)
13-19 190 ( 1) 725 ( 1) 178 ( 1) 6 ( 1) 1 ( 0) 1,101 ( 1)
20-24 1,313 ( 6) 3,153 ( 6) 1,195 ( 6) 29 ( 6) 25 ( 9) 5,720 ( 6)
25-29 3,756 (17) 8,066 (15) 3,303 (17) 58 (12) 44 (16) 15,233 (16)
30-34 5,062 (23) 12,186 (23) 4,682 (24) 99 (20) 68 (25) 22,135 (23)
35-39 4,281 (20) 11,835 (22) 3,925 (20) 90 (18) 53 (19) 20,213 (21)
40-44 2,720 (12) 7,791 (15) 2,500 (13) 69 (14) 27 (10) 13,119 (14)
45-49 1,421 ( 6) 3,555 ( 7) 1,315 ( 7) 50 (10) 21 ( 8) 6,374 ( 7)
50-54 785 ( 4) 1,812 ( 3) 698 ( 4) 24 ( 5) 11 ( 4) 3,333 ( 3)
55-59 556 ( 3) 1,043 ( 2) 446 ( 2) 16 ( 3) 6 ( 2) 2,069 ( 2)
60-64 394 ( 2) 633 ( 1) 223 ( 1) 18 ( 4) 3 ( 1) 1,272 ( 1)
65 or older 841 ( 4) 611 ( 1) 198 ( 1) 20 ( 4) 2 ( 1) 1,673 ( 2)
Female subtotal 21,929 (100) 53,707 (100) 19,548 (100) 497 (100) 274 (100) 96,075 (100)
 
Total 279,072 216,980 109,252 4,370 1,677 612,078
 
1
 
Includes 607 males and 120 females whose race/ethnicity is unknown.
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Table 9. AIDS cases, case-fatality rates, and deaths, by half-year and age group, through
June 1997, United States
 
1
Adults/adolescents Children <13 years old
Half-year
Cases diagnosed 
during interval
Case-fatality 
rate
Deaths occurring
during interval
Cases diagnosed
during interal
Case-fatality
rate
Deaths occurring 
during interval
Before 1981 85 91.8 29 8 75.0 1
1981 Jan.–June 107 88.8 37 10 80.0 2
July–Dec. 206 93.7 83 6 100.0 6
1982 Jan.–June 437 92.9 151 14 92.9 10
July–Dec. 727 92.3 296 17 82.4 4
1983 Jan.–June 1,352 94.3 527 33 100.0 14
July–Dec. 1,717 94.2 949 44 93.2 16
1984 Jan.–June 2,691 93.8 1,428 53 86.8 27
July–Dec. 3,513 94.2 2,026 66 86.4 24
1985 Jan.–June 5,175 92.9 2,875 113 82.3 47
July–Dec. 6,552 93.4 3,979 140 87.1 72
1986 Jan.–June 8,702 92.4 5,203 144 85.4 70
July–Dec. 10,254 92.9 6,729 199 80.9 98
1987 Jan.–June 13,556 91.8 7,813 229 80.3 121
July–Dec. 14,908 90.6 8,285 269 77.3 173
1988 Jan.–June 17,419 88.8 9,716 265 69.8 140
July–Dec. 17,887 88.9 11,070 347 70.0 179
1989 Jan.–June 21,039 86.2 12,755 367 69.5 175
July–Dec. 21,341 85.5 14,653 348 71.3 192
1990 Jan.–June 24,372 83.4 15,068 392 65.3 196
July–Dec. 23,749 82.2 16,052 408 60.0 199
1991 Jan.–June 28,462 79.6 17,129 409 60.6 174
July–Dec. 30,575 77.5 19,046 394 56.6 220
1992 Jan.–June 37,250 72.3 19,681 488 54.7 194
July–Dec. 40,169 69.0 20,906 448 57.1 226
1993 Jan.–June 42,367 59.8 21,309 439 51.9 254
July–Dec. 35,204 55.1 22,460 442 51.6 268
1994 Jan.–June 36,660 47.5 23,388 418 47.4 295
July–Dec. 32,786 40.4 24,275 351 44.4 253
1995 Jan.–June 34,505 31.5 23,806 303 32.7 263
July–Dec. 29,292 24.0 23,474 291 26.8 236
1996 Jan.–June 28,453 16.9 19,658 232 20.7 214
July–Dec. 21,341 12.1 13,852 150 12.7 159
1997 Jan.–June 11,323 6.4 5,551 65 10.8 71
Total2 604,176 62.0 374,656 7,902 58.2 4,602
1Persons whose vital status is unknown are included in counts of diagnosed cases, but excluded from counts of deaths.  Case-fatality rates are calcu-
lated for each half-year by date of diagnosis. Each 6-month case-fatality rate is the number of deaths ever reported among cases diagnosed in that
period (regardless of the year of death), divided by the number of total cases diagnosed in that period, multiplied by 100. For example, during the
interval January through June 1982, AIDS was diagnosed in 437 adults/adolescents. Through June 1997, 406 of these 437 were reported as dead.
Therefore, the case fatality rate is 92.9 (406 divided by 437, multiplied by 100). The case-fatality rates shown here may be underestimates because of
incomplete reporting of deaths. Reported deaths are not necessarily caused by HIV-related disease.
2Death totals include 397 adults/adolescents and 9 children known to have died, but whose dates of death are unknown.
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Table 10. AIDS cases by year of diagnosis and definition category, diagnosed through 
June 1997, United States
Period of diagnosis
Before
July 1993
July 1993–
June 1994
July 1994–
June 1995
July 1995–
June 1996
July 1996–
June 1997
Cumulative
total
Definition category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Pre-1987 definition 237,185 (62) 25,141 (35) 20,273 (30) 14,650 (25) 6,988 (21) 304,237 (50)
1987 definition 89,533 (24) 13,399 (18) 11,125 (16) 8,272 (14) 4,250 (13) 126,579 (21)
1993 definition1 53,544 (14) 34,184 (47) 36,547 (54) 35,346 (61) 21,641 (66) 181,262 (30)
Pulmonary tuberculosis 4,777 1,648 1,277 855 418 8,975
Recurrent pneumonia 1,812 1,055 882 732 367 4,848
Invasive cervical cancer 238 127 113 51 29 558
Severe HIV-related 
immunosuppression2 46,823 31,402 34,308 33,732 20,833 167,098
Total 380,262 (100) 72,724 (100) 67,945 (100) 58,268 (100) 32,879 (100) 612,078 (100)
1Persons who meet only the 1993 AIDS case definition and whose date of diagnosis is before January 1993 were diagnosed retrospectively. The sum
of diagnoses listed for the four conditions under the 1993 definition do not equal the 1993 definition total because some persons have more than one
diagnosis from the added conditions of pulmonary tuberculosis, recurrent pneumonia, and invasive cervical cancer.
2Defined as CD4+ T-lymphocyte count of less than 200 cells/µL or a CD4+ percentage less than 14 in persons with laboratory confirmation of HIV infec-
tion.
Table 11. Health care workers with documented and possible occupationally acquired 
AIDS/HIV infection, by occupation, reported through June 1997, United States1
Documented 
occupational transmission2 
Possible 
occupational transmission3
Occupation No. No.
Dental worker, including dentist – 7
Embalmer/morgue technician – 2
Emergency medical technician/paramedic – 10
Health aide/attendant 1 12
Housekeeper/maintenance worker 1 7
Laboratory technician, clinical 16 16
Laboratory technician, nonclinical 3 1
Nurse 21 29
Physician, nonsurgical 6 10
Physician, surgical – 6
Respiratory therapist 1 2
Technician, dialysis 1 3
Technician, surgical 2 2
Technician/therapist, other than those listed above – 5
Other health care occupations – 2
Total 52 114
1Health care workers are defined as those persons, including students and trainees, who have worked in a health care, clinical, or HIV laboratory set-
ting at any time since 1978. See MMWR 1992;41:823-25. 
2Health care workers who had documented HIV seroconversion after occupational exposure or had other laboratory evidence of occupational infec-
tion: 45 had percutaneous exposure, 5 had mucocutaneous exposure, 1 had both percutaneous and mucocutaneous exposures, and 1 had an
unknown route of exposure. Forty-seven exposures were to blood from an HIV-infected person, 1 to visibly bloody fluid, 1 to an unspecified fluid, and
3 to concentrated virus in a laboratory. Twenty-four of these health care workers developed AIDS. 
3These health care workers have been investigated and are without identifiable behavioral or transfusion risks; each reported percutaneous or muco-
cutaneous occupational exposures to blood or body fluids, or laboratory solutions containing HIV, but HIV seroconversion specifically resulting from
an occupational exposure was not documented. 
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Table 12. Adult/adolescent AIDS cases by single and multiple exposure categories, reported
through June 1997, United States
AIDS cases
Exposure category No. (%)
Single mode of exposure
Men who have sex with men 286,611 (47)
Injecting drug use 124,684 (21)
Hemophilia/coagulation disorder 3,673 ( 1)
Heterosexual contact 53,119 ( 9)
Receipt of transfusion1 8,063 ( 1)
Receipt of transplant of tissues, organs, or artificial insemination2 12 ( 0)
Other3 95 ( 0)
Single mode of exposure subtotal 476,257 (79)
Multiple modes of exposure
Men who have sex with men; injecting drug use 33,600 ( 6)
Men who have sex with men; hemophilia/coagulation disorder 151 ( 0)
Men who have sex with men; heterosexual contact 8,366 ( 1)
Men who have sex with men; receipt of transfusion/transplant 3,260 ( 1)
Injecting drug use; hemophilia/coagulation disorder 182 ( 0)
Injecting drug use; heterosexual contact 27,251 ( 5)
Injecting drug use; receipt of transfusion/transplant 1,541 ( 0)
Hemophilia/coagulation disorder; heterosexual contact 83 ( 0)
Hemophilia/coagulation disorder; receipt of transfusion/transplant 779 ( 0)
Heterosexual contact; receipt of transfusion/transplant 1,452 ( 0)
Men who have sex with men; injecting drug use; hemophilia/coagulation disorder 43 ( 0)
Men who have sex with men; injecting drug use; heterosexual contact 4,528 ( 1)
Men who have sex with men; injecting drug use; receipt of transfusion/transplant 573 ( 0)
Men who have sex with men; hemophilia/coagulation disorder; heterosexual contact 20 ( 0)
Men who have sex with men; hemophilia/coagulation disorder; receipt of transfusion/transplant 34 ( 0)
Men who have sex with men; heterosexual contact; receipt of transfusion/transplant 252 ( 0)
Injecting drug use; hemophilia/coagulation disorder; heterosexual contact 60 ( 0)
Injecting drug use; hemophilia/coagulation disorder; receipt of transfusion/transplant 36 ( 0)
Injecting drug use; heterosexual contact; receipt of transfusion/transplant 892 ( 0)
Hemophilia/coagulation disorder; heterosexual contact; receipt of transfusion/transplant 32 ( 0)
Men who have sex with men; injecting drug use; hemophilia/coagulation disorder; heterosexual contact; 8 ( 0)
Men who have sex with men; injecting drug use; hemophilia/coagulation disorder; receipt of transfusion/transplant 13
Men who have sex with men; injecting drug use; heterosexual contact; receipt of transfusion/transplant 153 ( 0)
Men who have sex with men; hemophilia/coagulation disorder; heterosexual contact; receipt of transfusion/transplant 5
Injecting drug use; hemophilia/coagulation disorder; heterosexual contact; receipt of transfusion/transplant 18 ( 0)
Men who have sex with men; injecting drug use; hemophilia/coagulation disorder; heterosexual contact; 
receipt of transfusion/transplant 5 ( 0)
Multiple modes of exposure subtotal 83,337 (14)
Risk not reported or identified4 44,582 ( 7)
Total 604,176 (100)
1Includes 37 adult/adolescents who developed AIDS after receiving blood screened negative for HIV antibody.
2Twelve adults developed AIDS after receiving tissue, organs, or artificial insemination from HIV-infected donors.  Four of the 12 received tissue or
organs from a single donor who was negative for HIV antibody at the time of donation.  See N Engl J Med 1992;326:726-32.
3See table 11 and figure 7 for a discussion of the "other" exposure category. "Other" also includes 63 persons who acquired HIV infection perinatally,
but were diagnosed with AIDS after age 13.
4See figure 7.
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Figure 1. Male adult/adolescent AIDS annual rates per 100,000 population, for cases 
reported July 1996 through June 1997, United States
Figure 2. Female adult/adolescent AIDS annual rates per 100,000 population, for cases 
reported July 1996 through June 1997, United States
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Figure 3. Male/adult adolescent AIDS cases reported July 1996 through June 1997, 
United States
Figure 4. Female adult/adolescent AIDS cases reported July 1996 through June 1997,
United States
(N=50,643)
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Figure 5. Pediatric AIDS cases reported July 1996 through June 1997, United States
Figure 6. Estimated incidence of AIDS, AIDS-opportunistic illness (AIDS-OI), and deaths in
persons with AIDS, adjusted for delays in reporting, by quarter-year of diagnosis/
death, United States, 1984–19961
1Estimated incidence of AIDS includes persons diagnosed using the 1993 expanded surveillance case definition, including persons whose AIDS diag-
nosis is based on evidence of severe immunosuppression (HIV-infected persons with CD4+ T-lymphocyte counts of less than 200 cells/µL or a CD4+
percentage of less than 14).  Estimated AIDS-OI incidence is the sum of the observed AIDS-OI incidence and the incidence based on estimated
dates of AIDS-OI diagnosis for persons reported with AIDS based only on severe immunosuppression.  Points on the figure represent quarterly inci-
dence; lines represent smoothed incidence.  Estimated incidence of AIDS, estimated AIDS-OIs, and deaths are all adjusted for delays in reporting.
Estimates are not adjusted for incomplete reporting of cases.  See Commentary.
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Figure 7. Results of investigations of adult/adolescent AIDS cases ever classified as risk 
not reported or identified, through June 1997, United States1
 
1Excludes 138 children under 13 years of age classified as “other/risk not reported or identified” in table 3: 129 whose risk is not identified, 2 who were
exposed to HIV-infected blood in a household setting, as supported by seroconversion, epidemiologic, and/or laboratory evidence (see MMWR
1992;41:228-31 and N Engl J Med 1993;329:1835-41) and 7 children who had sexual contact with an adult with or at  high risk for HIV infection (Xth
International Conference on AIDS; Yokohama; Japan, Aug. 7-12, 1994;2:258 [abstract PC 0401]).  An additional 411 children who were initially
reported without risk information have been reclassified after investigation.
2Cases associated with persons born in Pattern-II countries are no longer classified as heterosexual transmission. See Technical Notes.
3Investigations of these persons included patient interviews. Based on available information, these persons could not be reclassified into an exposure
category. This group includes persons possibly infected through heterosexual contact with a partner who is not known to be HIV infected or at  risk for
HIV infection; persons who may choose not to disclose high-risk information; and persons with possible occupational exposure. These 944 persons
report heterosexual contact, sexually transmitted disease infections, non-injecting drug use, hepatitis infections, and occupational exposures to blood
or body fluids.
4Ninety-five adults/adolescents are included in the “other” exposure category listed here and in table 3, and were exposed to HIV-infected blood, body
fluids, or concentrated virus in health care, laboratory, or household settings, as supported by seroconversion, epidemiologic, and/or laboratory evi-
dence. See table 11, MMWR 1993;42:329-31, MMWR 1993;42:948-51, and XI International Conference on AIDS; Vancouver, Canada; Jul. 7-12,
1996;1:179 [abstract Mo.D.1728]. One person was infected following intentional self-inoculation of blood from an HIV-infected person.  Sixty-three per-
sons acquired HIV infection perinatally and were diagnosed with AIDS after age 13. 
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Table 13. Estimated AIDS-opportunistic illness incidence, by region of residence and year of
diagnosis, 1991 through 1996, United States1
Region 
of residence2
Year of diagnosis
1991 1992 1993 1994 1995 1996
Northeast 15,500 16,900 18,100 18,600 19,000 17,400
Midwest 5,400 6,100 6,000 6,100 6,400 5,700
South 17,200 19,800 19,700 21,600 21,700 21,500
West 12,000 12,600 11,900 12,400 12,200 10,700
U.S. dependencies, 
possessions, and 
associated nations 2,050 2,075 2,125 1,925 2,000 1,875
Total3 52,200 57,600 57,900 60,600 61,300 57,200
1Estimates are adjusted for delays in the reporting of AIDS cases, but not for incomplete reporting of cases.  Estimates of less than 1,000, 1,000 to
2,499, 2,500 to 4,999, and 5,000 or more are rounded to the nearest 10, 25, 50, and 100, respectively.  Opportunistic illness refers to AIDS-defining
opportunistic illnesses included in the 1993 AIDS surveillance case definition.  Annual estimates are through the most recent year for which reliable
estimates are available.  Because there is uncertainty in AIDS-OI incidence, changes over time in AIDS-OI incidence should not be computed from
these rounded estimates.  See Technical Notes.
2See Technical Notes for a list of states or U.S. dependencies, possessions, and associated nations which comprise each region of residence.
3The sum of the regional estimates may not equal the total annual estimates because of rounding.
Table 14. Estimated AIDS-opportunistic illness incidence, by race/ethnicity and year of 
diagnosis, 1991 through 1996, United States1
Year of diagnosis
Race/ethnicity 1991 1992 1993 1994 1995 1996
White, not Hispanic 25,000 26,100 24,700 25,200 24,500 21,200
Black, not Hispanic 17,300 20,600 21,900 23,500 24,500 24,400
Hispanic 9,400 10,200 10,700 11,200 11,600 10,900
Asian/Pacific 
Islander 360 420 420 460 470 480
American Indian/
Alaska Native 140 160 170 200 200 190
Total2 52,200 57,600 57,900 60,600 61,300 57,200
1Estimates are adjusted for delays in the reporting of AIDS cases, but not for incomplete reporting of cases.  Estimates of less than 1,000, 1,000 to
2,499, 2,500 to 4,999, and 5,000 or more are rounded to the nearest 10, 25, 50, and 100, respectively.  Opportunistic illness refers to AIDS-defining
opportunistic illnesses included in the 1993 AIDS surveillance case definition.  Annual estimates are through the most recent year for which reliable
estimates are available.  Because there is uncertainty in AIDS-OI incidence, changes over time in AIDS-OI incidence should not be computed from
these rounded estimates.  See Technical Notes.
2Totals include estimates of persons whose race/ethnicity is unknown.
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Table 15. Estimated AIDS-opportunistic illness incidence, by age group, sex, exposure 
category, and year of diagnosis, 1991 through 1996, United States1
Male adult/adolescent
exposure category
Year of diagnosis
1991 1992 1993 1994 1995 1996
Men who have sex with men 28,000 29,200 28,100 29,300 28,600 25,500
Injecting drug use 10,100 11,800 12,400 12,800 12,900 12,100
Men who have sex with men
and inject drugs
3,650 3,950 3,600 3,650 3,600 3,050
Hemophilia/coagulation disorder 390 440 420 400 360 280
Heterosexual contact 1,500 2,075 2,500 2,900 3,450 3,800
Reciept of blood transfusion,
blood components, or tissue
430 390 320 350 330 340
Risk not reported or identified 340 360 280 140 140 130
Male sutotal 44,400 48,200 47,600 49,500 49,400 45,200
Female adult/adolescent
exposure category
Injecting drug use 3,700 4,300 4,600 4,750 4,950 4,750
Hemophilia/coagulation disorder 20 20 20 20 40 40
Heterosexual contact 2,850 3,650 4,400 5,100 5,900 6,300
Reciept of blood transfusion,
blood components, or tissue 300 300 280 310 310 310
Risk not reported or identified 160 160 100 70 70 70
Female subtotal 7,000 8,400 9,400 10,300 11,300 11,500
Pediatric (<13 years old)
exposure category2 800 940 900 810 660 520
Total3 52,200 57,600 57,900 60,600 61,300 57,200
1Estimates are adjusted for delays in the reporting of AIDS cases and anticipated redistribution of cases initially reported with no identified risk, but not
for incomplete reporting of cases.  Total estimates of less than 1,000, 1,000 to 2,499, 2,500 to 4,999, and 5,000 or more are rounded to the nearest
10, 25, 50, and 100, respectively.   Opportunistic illness refers to AIDS-defining opportunistic illnesses included in the 1993 AIDS surveillance case
definition.  Annual estimates are through the most recent year for which reliable estimates are available.  Because there is uncertainty in AIDS-OI inci-
dence, changes over time in AIDS-OI incidence should not be computed from these rounded estimates.  See Technical Notes.
2Estimates are based on cases diagnosed using the 1987 definition, adjusted for reporting delays.  The 1993 AIDS surveillance case definition
affected only adult/adolescent cases, not pediatric cases.
3The sum of the exposure category estimates may not equal the subtotal and total annual estimates because of rounding.
Table 16. Estimated deaths of persons with AIDS, by region of residence and year of death,
1991 through 1996, United States1
Region of residence2
Year of death
1991 1992 1993 1994 1995 1996
Northeast 11,700 12,900 13,900 15,800 16,100 12,600
Midwest 3,500 4,200 4,750 5,100 5,400 4,050
South 11,300 13,100 14,200 16,000 17,300 14,000
West 8,800 9,600 10,300 10,800 10,100 6,800
U.S. dependencies, 
possessions, and 
associated nations 1,300 1,375 1,525 1,725 1,725 1,725
Total3 36,600 41,100 44,600 49,400 50,700 39,200
1Estimates are adjusted for delays in the reporting of deaths, but not for incomplete reporting of deaths.  Estimates of less than 1,000, 1,000 to 2,499,
2,500 to 4,999, and 5,000 or more are rounded to the nearest 10, 25, 50, and 100, respectively.  Annual estimates are through the most recent year
for which reliable estimates are available.  Because there is uncertainty in the estimates of deaths of persons with AIDS, changes over time in the esti-
mates of deaths of persons with AIDS should not be computed from these rounded estimates.  See Technical Notes.
2See Technical Notes for a list of states or U.S. dependencies, possessions, and asociated nations which comprise each region of residence.
3The sum of the regional estimates may not equal the total annual estimates because of  rounding.
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Table 17. Estimated deaths of persons with AIDS, by race/ethnicity and year of death, 1991
through 1996, United States1
Year of death
Race/ethnicity 1991 1992 1993 1994 1995 1996
White, not Hispanic 18,900 20,400 21,400 22,300 21,800 14,700
Black, not Hispanic 11,100 13,300 15,200 17,800 19,100 16,700
Hispanic 6,200 7,100 7,600 8,700 9,100 7,300
Asian/Pacific 
Islander 250 270 300 400 360 290
American Indian/
Alaska Native 90 80 130 140 180 100
Total2 36,600 41,100 44,600 49,400 50,700 39,200
1Estimates are adjusted for delays in the reporting of deaths, but not for incomplete reporting of deaths.  Estimates of less than 1,000, 1,000 to 2,499,
2,500 to 4,999, and 5,000 or more are rounded to the nearest 10, 25, 50, and 100, respectively.  Annual estimates are through the most recent year
for which reliable estimates are available.  Because there is uncertainty in the estimates of deaths of persons with AIDS, changes over time in the esti-
mates of deaths of persons with AIDS should not be computed from these rounded estimates.  See Technical Notes.
2Totals include estimates of persons whose race/ethnicity is unknown.
Table 18. Estimated deaths of persons with AIDS, by age group, sex, exposure category,
and year of death, 1991 through 1996, United States1
Male adult/adolescent
exposure category
Year of death
1991 1992 1993 1994 1995 1996
Men who have sex with men 21,000 22,800 23,700 25,100 24,900 17,300
Injecting drug use 6,800 8,000 9,100 10,200 10,800 9,000
Men who have sex with men
and inject drugs 2,425 2,700 3,000 3,300 3,300 2,500
Hemophilia/coagulation disorder 270 320 340 330 310 220
Heterosexual contact 820 1,175 1,525 1,925 2,300 2,125
Reciept of blood transfusion,
blood components, or tissue 380 330 320 310 280 240
Risk not reported or identified 210 240 200 170 130 80
Male sutotal 31,900 35,600 38,100 41,400 42,000 31,400
Female adult/adolescent
exposure category
Injecting drug use 2,250 2,700 3,050 3,650 3,850 3,450
Hemophilia/coagulation disorder 10 20 20 20 20 20
Heterosexual contact 1,625 1,950 2,600 3,450 4,000 3,650
Reciept of blood transfusion,
blood components, or tissue 250 260 240 240 250 200
Risk not reported or identified 80 120 90 70 60 40
Female subtotal 4,250 5,100 6,000 7,400 8,100 7,300
Pediatric (<13 years old)
exposure category 390 420 530 560 530 440
Total2 36,600 41,100 44,600 49,400 50,700 39,200
1Estimates are adjusted for delays in the reporting of deaths, but not for incomplete reporting of deaths.  Total estimates of less than 1,000, 1,000 to
2,499, 2,500 to 4,999, and 5,000 or more are rounded to the nearest 10, 25, 50, and 100, respectively.   Annual estimates are through the most recent
year for which reliable estimates are available.  Because there is uncertainty in the estimates of deaths of persons with AIDS, changes over time in the
estimates of deaths of persons with AIDS should not be computed from these rounded estimates.  See Technical Notes.
2The sum of the exposure category estimates may not equal the total annual estimates because of rounding.
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Table 19. Estimated persons living with AIDS, by region of residence and year, 1991 through
1996, United States1
Region of residence2
Year 
1991 1992 1993 1994 1995 1996
Northeast 29,100 39,000 50,800 58,100 64,400 71,000
Midwest 10,800 15,100 18,300 20,200 21,600 23,300
South 33,300 46,900 59,400 69,100 76,700 87,700
West 24,300 33,000 38,900 42,400 45,500 49,900
U.S. dependencies, 
possessions, and 
associated nations 3,500 4,600 5,700 6,400 6,800 7,100
Total3 101,000 138,600 173,100 196,200 215,000 239,000
1Estimates of persons living with AIDS are derived by subtracting the estimated cumulative number of deaths in persons with AIDS from the estimated
cumulative number of persons with AIDS.  Estimated AIDS cases and estimated deaths are adjusted for reporting delays, but not for incomplete
reporting.  Estimates of less than 1,000, 1,000 to 2,499, 2,500 to 4,999, and 5,000 or more are rounded to the nearest 10, 25, 50, and 100, respec-
tively.   Annual estimates are through the most recent year for which reliable estimates are available.  Because there is uncertainty in the estimates of
persons living with AIDS, changes over time in the estimates of persons living with AIDS should not be computed from these rounded estimates.  See
Technical Notes.
2See Technical Notes for a list of states or U.S. dependencies, possessions, and associated nations which comprise each region of residence.
3The sum of the regional estimates may not equal the total annual estimates because of rounding.
Table 20. Estimated persons living with AIDS, by race/ethnicity and year, 1991 through 1996,
United States1
Race/ethnicity
Year 
1991 1992 1993 1994 1995 1996
White, not Hispanic 51,900 68,000 80,000 86,200 91,100 98,200
Black, not Hispanic 31,200 45,500 60,400 71,500 80,900 92,200
Hispanic 16,800 23,500 30,800 36,000 40,400 45,400
Asian/Pacific 
Islander 690 1,000 1,275 1,425 1,575 1,850
American Indian/
Alaska Native 280 450 540 640 700 800
Total2 101,000 138,600 173,100 196,200 215,000 239,000
1Estimates of persons living with AIDS are derived by subtracting the estimated cumulative number of deaths in persons with AIDS from the estimated
cumulative number of persons with AIDS.  Estimated AIDS cases and estimated deaths are adjusted for reporting delays, but not for incomplete
reporting.  Estimates of less than 1,000, 1,000 to 2,499, 2,500 to 4,999, and 5,000 or more are rounded to the nearest 10, 25, 50, and 100, respec-
tively.    Annual estimates are through the most recent year for which reliable estimates are available.  See Technical Notes.
2Totals include estimates of persons whose race/ethnicity is unknown.
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Table 21. Estimated persons living with AIDS, by age group, sex, exposure category, 
and year, 1991 through 1996, United States1
Male adult/adolescent
exposure category
Year 
1991 1992 1993 1994 1995 1996
Men who have sex with men 55,400 72,800 86,900 95,500 102,000 111,900
Injecting drug use 17,900 25,800 34,100 39,700 43,800 48,000
Men who have sex with men
and inject drugs 8,100 10,900 12,800 13,600 14,200 14,700
Hemophilia/coagulation disorder 970 1,400 1,575 1,650 1,650 1,650
Heterosexual contact 2,375 4,000 6,000 7,700 9,600 12,300
Reciept of blood transfusion,
blood components, or tissue 700 860 970 1,050 1,150 1,275
Risk not reported or identified 910 1,125 1,225 1,175 1,200 1,275
Male sutotal 86,400 116,800 143,500 160,400 173,600 191,000
Female adult/adolescent
exposure category
Injecting drug use 6,900 10,100 13,500 15,800 17,800 19,700
Hemophilia/coagulation disorder 40 60 80 90 110 130
Heterosexual contact 4,750 7,900 11,800 15,100 18,600 22,900
Reciept of blood transfusion,
blood components, or tissue 550 690 830 950 1,050 1,225
Risk not reported or identified 340 420 460 460 470 510
Female subtotal 12,500 19,200 26,700 32,500 38,100 44,400
Pediatric (<13 years old)
exposure category 2,125 2,650 3,000 3,250 3,400 3,450
Total2 101,000 138,600 173,100 196,200 215,000 239,000
1Estimates of persons living with AIDS are derived by subtracting the estimated cumulative number of deaths in persons with AIDS from the estimated
cumulative number of persons with AIDS.  Estimated AIDS cases and estimated deaths are adjusted for reporting delays, but not for incomplete
reporting.  Total estimates of less than 1,000, 1,000 to 2,499, 2,500 to 4,999, and 5,000 or more are rounded to the nearest 10, 25, 50, and 100,
respectively.     Annual estimates are through the most recent year for which reliable estimates are available.  Because there is uncertainty in the esti-
mates of persons living with AIDS, changes over time in the estimates of persons living with AIDS should not be computed from these rounded esti-
mates.  See Technical Notes.
2The sum of exposure category estimates may not equal the total annual estimates because of rounding.
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Table 22. HIV infection cases1 by state, reported July 1995 through June 1996, July 1996
through June 1997; and cumulative totals, by state and age group, through June
1997, from states with confidential HIV infection reporting
Cumulative totals
State of residence 
(Date HIV reporting initiated)
July 1995–
June 1996
July 1996–
June 1997
Adults/
adolescents
Children
<13 years old Total
Alabama (Jan. 1988) 540 531 4,299 36 4,335
Arizona (Jan. 1987) 374 385 3,537 37 3,574
Arkansas (July 1989) 224 218 1,534 19 1,553
Colorado (Nov. 1985) 359 405 5,154 29 5,183
Connecticut (July 1992)2 12 11 – 95 95
Idaho (June 1986) 26 33 280 2 282
Indiana (July 1988) 374 469 2,895 23 2,918
Louisiana (Feb. 1993) 1,022 1,239 5,128 93 5,221
Michigan (April 1992) 848 745 3,806 96 3,902
Minnesota (Oct. 1985) 213 219 2,185 25 2,210
Mississippi (Aug. 1988) 536 538 3,489 40 3,529
Missouri (Oct. 1987) 529 533 3,626 42 3,668
Nebraska (Sept. 1995) 214 102 315 5 320
Nevada (Feb. 1992) 382 447 2,419 20 2,439
New Jersey (Jan. 1992) 1,936 2,282 11,676 330 12,006
North Carolina (Feb. 1990) 1,217 1,008 7,340 95 7,435
North Dakota (Jan. 1988) 4 6 63 – 63
Ohio (June 1990) 709 429 3,621 55 3,676
Oklahoma (June 1988) 239 222 1,819 12 1,831
Oregon (Sept. 1988)2 – 3 – 3 3
South Carolina (Feb. 1986) 746 722 5,995 108 6,103
South Dakota (Jan. 1988) 17 12 168 5 173
Tennessee (Jan. 1992) 861 855 4,178 43 4,221
Texas (Feb. 1994)2 37 30 – 223 223
Utah (April 1989) 105 88 785 4 789
Virginia (July 1989) 1,188 908 6,595 69 6,664
West Virginia (Jan. 1989) 70 66 426 1 427
Wisconsin (Nov. 1985) 268 246 2,054 30 2,084
Wyoming (June 1989) 7 11 59 – 59
Subtotal 13,057 12,763 83,446 1,540 84,986
Persons reported from states 
with confidential HIV reporting who 
were residents of other states3 314 348 1,940 46 1,986
Total 13,371 13,111 85,386 1,586 86,972
1Includes only persons reported with HIV infection who have not developed AIDS.
2Connecticut and Texas have confidential HIV infection reporting for pediatric cases only; Oregon has confidential reporting for children less than 6
years old.
3Includes 294 persons reported from states with confidential HIV infection reporting, but whose state of residence is unknown.  See Technical Notes.
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Table 23. Male adult/adolescent HIV infection cases1 by exposure category and
race/ethnicity, reported July 1996 through June 1997, and cumulative totals
through June 1997, from states with confidential HIV infection reporting2
White, not Hispanic Black, not Hispanic Hispanic 
July 1996–
June 1997
Cumulative 
total
July 1996–
June 1997
Cumulative 
total
July 1996–
June 1997
Cumulative 
total 
Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Men who have sex with men 2,238 (60) 17,382 (61) 1,281 (29) 9,561 (32) 230 (35) 1,360 (35)
Injecting drug use 363 (10) 2,591 ( 9) 768 (17) 6,279 (21) 152 (23) 1,069 (28)
Men who have sex with men and 
inject drugs 227 ( 6) 2,342 ( 8) 145 ( 3) 1,542
( 5)
30 ( 5) 243 ( 6)
Hemophilia/coagulation disorder 19 ( 1) 318 ( 1) 8 ( 0) 75 ( 0) 2 ( 0) 10 ( 0)
Heterosexual contact: 113 ( 3) 719 ( 3) 400 ( 9) 2,633 ( 9) 43 ( 6) 226 ( 6)
Sex with an injecting drug user 25 195 82 648 14 78
Sex with person with hemophilia – 3 1 7 – –
Sex with transfusion recipient 
with HIV infection 4 19 5 44 – 2
Sex with HIV-infected person, 
risk not specified 84 502 312 1,934 29 146
Receipt of blood tranfusion, 
blood components, or tissue 11 ( 0) 168 ( 1) 26 ( 1) 155 ( 1) 1 ( 0) 24 ( 1)
Risk not reported or identified3 764 (20) 5,091 (18) 1,801 (41) 9,688 (32) 208 (31) 931 (24)
Total 3,735 (100) 28,611 (100) 4,429 (100) 29,933 (100) 666 (100) 3,863 (100)
Asian/Pacific Islander American Indian/Alaska Native Cumulative totals4
July 1996–
June 1997
Cumulative 
total
July 1996–
June 1997
Cumulative 
total
July 1996–
June 1997
Cumulative 
total
Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Men who have sex with men 11 (34) 85 (47) 27 (43) 177 (48) 3,824 (42) 28,795 (45)
Injecting drug use – – 15 ( 8) 6 (10) 56 (15) 1,303 (14) 10,074 (16)
Men who have sex with men and 
inject drugs 2 ( 6) 4 ( 2) 4 ( 6) 51 (14) 411 ( 5) 4,206 ( 7)
Hemophilia/coagulation disorder 1 ( 3) 2 ( 1) – – 2 ( 1) 31 ( 0) 413 ( 1)
Heterosexual contact: 3 ( 9) 10 ( 6) 2 ( 3) 17 ( 5) 562 ( 6) 3,621 ( 6)
Sex with an injecting drug user 2 5 1 6 124 937
Sex with person with hemophilia – – – – 1 10
Sex with transfusion recipient 
with HIV infection – – – – 10 66
Sex with HIV-infected person, 
risk not specified 1 5 1 11 427 2,608
Receipt of blood tranfusion, 
blood components, or tissue – – 1 ( 1) – – 3 ( 1) 38 ( 0) 356 ( 1)
Risk not reported or identified 15 (47) 64 (35) 24 (38) 63 (17) 2,929 (32) 16,605 (26)
Total 32 (100) 181 (100) 63 (100) 369 (100) 9,098 (100) 64,070 (100)
1Includes only persons reported with HIV infection who have not developed AIDS.
2See table 22 for states with confidential HIV infection reporting.
3For HIV infection cases, "risk not reported or identified" refers primarily to persons whose mode of exposure was not reported and who have not been
followed up to determine their mode of exposure, and to a smaller number of persons who are not reported with one of the exposures listed above
after follow-up. See Technical Notes.
4Includes 1,113 men whose race/ethnicity is unknown.
HIV/AIDS Surveillance Report 28 Vol. 9, No. 1
Table 24. Female adult/adolescent HIV infection cases1 by exposure category and
race/ethnicity, reported July 1996 through June 1997, and cumulative totals
through June 1997, from states with confidential HIV infection reporting2
White, not Hispanic Black, not Hispanic Hispanic 
July 1996–
June 1997
Cumulative 
total
July 1996–
June 1997
Cumulative 
total
July 1996–
June 1997
Cumulative 
total
Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Injecting drug use 181 (22) 1,551 (29) 408 (16) 3,273 (23) 50 (18) 347 (27)
Hemophilia/coagulation disorder 3 ( 0) 11 ( 0) 1 ( 0) 9 ( 0) – – – –
Heterosexual contact: 325 (39) 2,129 (40) 884 (35) 5,262 (37) 120 (44) 520 (41)
Sex with an injecting drug user 112 798 196 1,583 41 228
Sex with a bisexual male 34 260 52 389 3 20
Sex with person with hemophilia 7 54 3 29 – 5
Sex with transfusion recipient 
with HIV infection 3 27 8 40 1 5
Sex with HIV-infected person, 
risk not specified 169 990 625 3,221 75 262
Receipt of blood tranfusion, 
blood components, or tissue 9 ( 1) 114 ( 2) 30 ( 1) 218 ( 2) 1 ( 0) 19 ( 2)
Risk not reported or identified3 314 (38) 1,527 (29) 1,215 (48) 5,479 (38) 103 (38) 377 (30)
Total 832 (100) 5,332 (100) 2,538 (100) 14,241 (100) 274 (100) 1,263 (100)
Asian/Pacific Islander American Indian/Alaska Native Cumulative totals4
July 1996–
June 1997
Cumulative 
total
July 1996–
June 1997
Cumulative 
total
July 1996–
June 1997
Cumulative 
total
Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Injecting drug use 2 ( 9) 8 (12) 8 (30) 51 (37) 653 (17) 5,253 (25)
Hemophilia/coagulation disorder – – – – – – – – 4 ( 0) 20 ( 0)
Heterosexual contact: 6 (27) 23 (35) 11 (41) 53 (38) 1,352 (36) 8,017 (38)
Sex with an injecting drug user 1 6 5 30 357 2,652
Sex with a bisexual male – 1 1 7 90 681
Sex with person with hemophilia – – – – 10 88
Sex with transfusion recipient 
with HIV infection – – – – 12 72
Sex with HIV-infected person, 
risk not specified 5 16 5 16 883 4,524
Receipt of blood tranfusion, 
blood components, or tissue – – 1 ( 2) – – 1 ( 1) 40 ( 1) 355 ( 2)
Risk not reported or identified 14 (64) 34 (52) 8 (30) 33 (24) 1,701 (45) 7,659 (36)
Total 22 (100) 66 (100) 27 (100) 138 (100) 3,750 (100) 21,304 (100)
1Includes only persons reported with HIV infection who have not developed AIDS.
2See table 22 for states with confidential HIV infection reporting.
3For HIV infection cases, "risk not reported or identified" refers primarily to persons whose mode of exposure was not reported and who have not been
followed up to determine their mode of exposure, and to a smaller number of persons who are not reported with one of the exposures listed above
after follow-up. See Technical Notes.
4Includes 264 women whose race/ethnicity is unknown.
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Table 25. Pediatric HIV infection cases1 by exposure category and race/ethnicity, reported
July 1996 through June 1997, and cumulative totals through June 1997, from
states with confidential HIV infection reporting2
White, not Hispanic Black, not Hispanic Hispanic
July 1996–
June 1997
Cumulative 
total
July 1996–
June 1997
Cumulative 
total
July 1996–
June 1997
Cumulative 
total 
Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Hemophilia/coagulation disorder 1 ( 2) 65 (17) – – 18 ( 2) – – 5 ( 3)
Mother with/at risk for HIV infection: 49 (92) 288 (74) 149 (90) 892 (91) 30 (88) 162 (88)
Injecting drug use 16 86 48 288 2 39
Sex with injecting drug user 11 57 23 109 8 32
Sex with bisexual male 1 4 1 16 – 2
Sex with person with hemophilia – 3 – 2 – –
Sex with transfusion recipient 
with HIV infection – 4 1 3 – –
Sex with HIV-infected person, 
risk not specified 9 55 31 160 11 33
Receipt of blood transfusion, 
blood components, or tissue 1 7 – 10 – 2
Has HIV infection, risk not specified 11 72 45 304 9 54
Receipt of blood transfusion, blood 
components, or tissue – – 18 ( 5) 1 ( 1) 8 ( 1) – – 4 ( 2)
Risk not reported or identified3 3 ( 6) 18 ( 5) 16 (10) 61 ( 6) 4 (12) 13 ( 7)
Total 53 (100) 389 (100) 166 (100) 979 (100) 34 (100) 184 (100)
Asian/Pacific Islander
American Indian/
Alaska Native Cumulative totals4
July 1996–
June 1997
Cumulative 
total
July 1996–
June 1997
Cumulative 
total
July 1996–
June 1997
Cumulative 
total 
Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Hemophilia/coagulation disorder – – 1 (14) – – 1 (10) 1 ( 0) 92 ( 6)
Mother with/at risk for HIV infection: 1 (100) 3 (43) – – 7 (70) 232 (89) 1,360 (86)
Injecting drug use – 1 – 3 67 420
Sex with injecting drug user – – – 1 43 200
Sex with bisexual male 1 2 – – 3 25
Sex with person with hemophilia – – – 1 – 6
Sex with transfusion recipient 
with HIV infection – – – – 1 7
Sex with HIV-infected person, 
risk not specified – – – – 51 248
Receipt of blood transfusion, 
blood components, or tissue – – – – 1 19
Has HIV infection, risk not specified – – – 2 66 435
Receipt of blood transfusion, blood
components, or tissue – – – – – – – – 1 ( 0) 31 ( 2)
Risk not reported or identified – – 3 (43) – – 2 (20) 27 (10) 103 ( 6)
Total 1 (100) 7 (100) – – 10 (100) 261 (100) 1,586 (100)
1Includes only persons reported with HIV infection who have not developed AIDS.
2See table 22 for states with confidential HIV infection reporting.
3For HIV infection cases, "risk not reported or identified" refers primarily to persons whose mode of exposure was not reported and who have not been
followed up to determine their mode of exposure, and to a smaller number of persons who are not reported with one of the exposures listed above
after follow-up. See Technical Notes.
4Includes 17 children whose race/ethnicity is unknown.
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Table 26. HIV infection cases1 in adolescents and adults under age 25, by sex and exposure
category, reported July 1996 through June 1997, and cumulative totals through
June 1997, from states with confidential HIV infection reporting2
13-19 years old 20-24 years old 
July 1996–
June 1997
Cumulative 
total
July 1996–
June 1997
Cumulative 
total 
Male exposure category No. (%) No. (%) No. (%) No. (%) 
Men who have sex with men 82 (44) 735 (46) 496 (53) 4,818 (54)
Injecting drug use 9 ( 5) 86 ( 5) 51 ( 5) 523 ( 6)
Men who have sex with men 
and inject drugs 8 ( 4) 90 ( 6) 39 ( 4) 586 ( 7)
Hemophilia/coagulation disorder 5 ( 3) 99 ( 6) 4 ( 0) 84 ( 1)
Heterosexual contact: 12 ( 6) 107 ( 7) 45 ( 5) 493 ( 6)
Sex with injecting drug user – 20 3 84
Sex with person with hemophilia – 1 – 1
Sex with transfusion recipient 
with HIV infection – 1 1 7
Sex with HIV-infected person, 
risk not specified 12 85 41 401
Receipt of blood transfusion,
blood components, or tissue 1 ( 1) 10 ( 1) 5 ( 1) 36 ( 0)
Risk not reported or identified3 68 (37) 477 (30) 302 (32) 2,325 (26)
Male subtotal 185 (100) 1,604 (100) 942 (100) 8,865 (100)
Female exposure category 
Injecting drug use 14 ( 4) 130 ( 7) 53 ( 9) 543 (14)
Hemophilia/coagulation disorder – – – – – – 2 ( 0)
Heterosexual contact: 134 (40) 816 (47) 249 (41) 1,640 (43)
Sex with injecting drug user 21 190 55 468
Sex with bisexual male 9 59 21 157
Sex with person with hemophilia 3 15 2 28
Sex with transfusion recipient 
with HIV infection 2 4 1 16
Sex with HIV-infected person, 
risk not specified 99 548 170 971
Receipt of blood transfusion, 
blood components, or tissue 2 ( 1) 15 ( 1) 3 ( 0) 28 ( 1)
Risk not reported or identified 186 (55) 793 (45) 300 (50) 1,593 (42)
Female subtotal 336 (100) 1,754 (100) 605 (100) 3,806 (100)
Total4 521 3,359 1,548 12,673
1Includes only persons reported with HIV infection who have not developed AIDS.
2See table 22 for states with confidential HIV infection reporting.
3For HIV infection cases, “risk not reported or identified” refers primarily to persons whose mode of exposure was not reported and who have not been
followed up to determine their mode of exposure, and to a smaller number of persons who are not reported with one of the exposures listed above
after follow-up.  See Technical Notes.
4Includes 3 persons whose sex is unknown.
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Table 27. HIV infection cases1 by sex, age at diagnosis, and race/ethnicity, reported 
through June 1997, from states with confidential HIV infection reporting2
Male
Age at diagnosis (years)
White, 
not Hispanic
Black, 
not Hispanic Hispanic
Asian/Pacific 
Islander
American Indian/
Alaska Native Total3
No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Under 5 136 ( 0) 403 ( 1) 71 ( 2) 2 ( 1) 2 ( 1) 615 ( 1)
5–12 82 ( 0) 76 ( 0) 25 ( 1) 1 ( 1) 1 ( 0) 190 ( 0)
13–19 606 ( 2) 901 ( 3) 59 ( 1) 6 ( 3) 8 ( 2) 1,604 ( 2)
20–24 4,089 (14) 4,048 (13) 504 (13) 29 (16) 70 (19) 8,865 (14)
25–29 7,136 (25) 6,153 (20) 969 (24) 49 (27) 104 (28) 14,653 (23)
30–34 6,940 (24) 6,691 (22) 976 (25) 43 (23) 84 (23) 14,993 (23)
35–39 4,628 (16) 5,485 (18) 695 (18) 24 (13) 52 (14) 11,086 (17)
40–44 2,618 ( 9) 3,557 (12) 381 (10) 16 ( 9) 26 ( 7) 6,723 (10)
45–49 1,322 ( 5) 1,644 ( 5) 152 ( 4) 8 ( 4) 12 ( 3) 3,210 ( 5)
50–54 686 ( 2) 760 ( 2) 56 ( 1) 3 ( 2) 5 ( 1) 1,542 ( 2)
55–59 285 ( 1) 356 ( 1) 38 ( 1) – – 5 ( 1) 694 ( 1)
60–64 155 ( 1) 180 ( 1) 19 ( 0) 1 ( 1) 3 ( 1) 366 ( 1)
65 or older 146 ( 1) 158 ( 1) 14 ( 0) 2 ( 1) – – 334 ( 1)
Male subtotal 28,829 (100) 30,412 (100) 3,959 (100) 184 (100) 372 (100) 64,875 (100)
Female
Age at diagnosis (years)
Under 5 139 ( 3) 412 ( 3) 70 ( 5) 3 ( 4) 6 ( 4) 639 ( 3)
5–12 32 ( 1) 88 ( 1) 18 ( 1) 1 ( 1) 1 ( 1) 142 ( 1)
13–19 374 ( 7) 1,271 ( 9) 76 ( 6) 4 ( 6) 15 (10) 1,754 ( 8)
20–24 1,022 (19) 2,518 (17) 193 (14) 16 (23) 24 (17) 3,806 (17)
25–29 1,227 (22) 3,068 (21) 313 (23) 16 (23) 23 (16) 4,708 (21)
30–34 1,157 (21) 2,939 (20) 309 (23) 15 (21) 29 (20) 4,515 (20)
35–39 753 (14) 2,195 (15) 179 (13) 7 (10) 24 (17) 3,194 (14)
40–44 359 ( 7) 1,226 ( 8) 94 ( 7) 4 ( 6) 18 (12) 1,728 ( 8)
45–49 221 ( 4) 525 ( 4) 52 ( 4) 2 ( 3) 4 ( 3) 820 ( 4)
50–54 84 ( 2) 234 ( 2) 24 ( 2) 1 ( 1) 1 ( 1) 348 ( 2)
55–59 46 ( 1) 128 ( 1) 17 ( 1) 1 ( 1) – – 194 ( 1)
60–64 31 ( 1) 62 ( 0) 4 ( 0) – – – – 97 ( 0)
65 or older 58 ( 1) 75 ( 1) 2 ( 0) – – – – 140 ( 1)
Female subtotal 5,503 (100) 14,741 (100) 1,351 (100) 70 (100) 145 (100) 22,085 (100)
Total4 34,333 45,156 5,310 254 517 86,972
1Includes only persons reported with HIV infection who have not developed AIDS.
2See table 22 for states with confidential HIV infection reporting.
3Includes 1,119 males, 275 females, and 8 persons of unknown sex whose race/ethnicity is unknown.
4Includes 12 persons whose sex is unknown.
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Table 28. Persons reported to be living with HIV infection1 and with AIDS, by state and age
group, reported through June 19972
U.S. state of residence 
(Date HIV reporting 
initiated)
Living with HIV infection3 Living with AIDS4 Cumulative totals
Adults/
adolescents
Children
<13 years old Total
Adults/
adolescents
Children
<13 years old Total
Adults/
adolescents
Children
<13 years old Total
Alabama (Jan. 1988) 4,144 35 4,179 1,956 21 1,977 6,100 56 6,156
Alaska – – – 182 2 184 182 2 184
Arizona (Jan. 1987) 3,168 34 3,202 1,806 6 1,812 4,974 40 5,014
Arkansas (July 1989) 1,511 19 1,530 1,077 17 1,094 2,588 36 2,624
California – – – 34,627 205 34,832 34,627 205 34,832
Colorado (Nov. 1985) 4,976 28 5,004 2,352 7 2,359 7,328 35 7,363
Connecticut (July 1992)5 – 87 87 4,344 80 4,424 4,344 167 4,511
Delaware – – – 850 7 857 850 7 857
District of Columbia – – – 4,112 81 4,193 4,112 81 4,193
Florida – – – 25,326 574 25,900 25,326 574 25,900
Georgia – – – 7,662 77 7,739 7,662 77 7,739
Hawaii – – – 682 4 686 682 4 686
Idaho (June 1986) 230 2 232 160 – 160 390 2 392
Illinois – – – 6,493 104 6,597 6,493 104 6,597
Indiana (July 1988) 2,798 22 2,820 2,031 14 2,045 4,829 36 4,865
Iowa – – – 435 4 439 435 4 439
Kansas – – – 712 3 715 712 3 715
Kentucky – – – 963 12 975 963 12 975
Louisiana (Feb. 1993) 4,947 86 5,033 3,983 57 4,040 8,930 143 9,073
Maine – – – 337 8 345 337 8 345
Maryland – – – 6,656 147 6,803 6,656 147 6,803
Massachusetts – – – 4,126 76 4,202 4,126 76 4,202
Michigan (April 1992) 3,188 81 3,269 3,459 28 3,487 6,647 109 6,756
Minnesota (Oct. 1985) 2,061 23 2,084 1,207 10 1,217 3,268 33 3,301
Mississippi (Aug. 1988) 3,372 40 3,412 1,232 21 1,253 4,604 61 4,665
Missouri (Oct. 1987) 3,507 41 3,548 3,211 16 3,227 6,718 57 6,775
Montana – – – 115 1 116 115 1 116
Nebraska (Sept. 1995) 301 5 306 327 4 331 628 9 637
Nevada (Feb. 1992) 2,198 19 2,217 1,512 13 1,525 3,710 32 3,742
New Hampshire – – – 379 3 382 379 3 382
New Jersey (Jan. 1992) 10,615 318 10,933 11,906 259 12,165 22,521 577 23,098
New Mexico – – – 598 3 601 598 3 601
New York – – – 36,362 729 37,091 36,362 729 37,091
North Carolina (Feb. 1990) 6,773 89 6,862 2,797 50 2,847 9,570 139 9,709
North Dakota (Jan. 1988) 55 – 55 33 – 33 88 – 88
Ohio (June 1990) 3,224 53 3,277 3,055 36 3,091 6,279 89 6,368
Oklahoma (June 1988) 1,734 11 1,745 1,200 9 1,209 2,934 20 2,954
Oregon (Sept. 1988)5 – 3 3 1,552 5 1,557 1,552 8 1,560
Pennsylvania – – – 7,160 127 7,287 7,160 127 7,287
Rhode Island – – – 686 3 689 686 3 689
South Carolina (Feb. 1986) 5,707 106 5,813 2,960 25 2,985 8,667 131 8,798
South Dakota (Jan. 1988) 152 5 157 44 1 45 196 6 202
Tennessee (Jan. 1992) 4,056 43 4,099 2,722 18 2,740 6,778 61 6,839
Texas (Feb.1994)5 – 211 211 17,006 127 17,133 17,006 338 17,344
Utah (April 1989) 773 4 777 599 6 605 1,372 10 1,382
Vermont – – – 137 1 138 137 1 138
Virginia (July 1989) 6,177 67 6,244 3,732 81 3,813 9,909 148 10,057
Washington – – – 3,115 14 3,129 3,115 14 3,129
West Virginia (Jan. 1989) 396 1 397 330 3 333 726 4 730
Wisconsin (Nov. 1985) 1,932 29 1,961 1,228 9 1,237 3,160 38 3,198
Wyoming (June 1989) 55 – 55 58 2 60 113 2 115
Subtotal 78,050 1,462 79,512 219,594 3,110 222,704 297,644 4,572 302,216
U.S. dependencies, possessions, and associated nations
Guam – – – 7 – 7 7 – 7
Pacific Islands, U.S. – – – 2 – 2 2 – 2
Puerto Rico – – – 6,746 166 6,912 6,746 166 6,912
Virgin Islands, U.S. – – – 166 8 174 166 8 174
Total 78,050 1,462 79,512 226,726 3,285 230,011 304,776 4,747 309,523
1Includes only persons reported with HIV infection who have not developed AIDS.
2Persons reported with vital status "alive" as of the last update. Excludes persons whose vital status is unknown.
3Includes only persons reported from states with confidential HIV reporting. Excludes 1,789 adults/adolescents and 42 children reported from states with confidential HIV
infection reporting whose state of residence is unknown or are residents of other states.
4Includes 211 adults/adolescents and 1 child whose state of residence is unknown.
5Connecticut and Texas have confidential HIV infection reporting for pediatric cases only; Oregon has confidential infection reporting for children less than 6 years old.
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Technical Notes
Surveillance of AIDS 
All 50 states, the District of Columbia, U.S. depen-
dencies and possessions, and independent nations in
free association with the United States1 report AIDS
cases to CDC using a uniform surveillance case defi-
nition and case report form. The original definition was
modified in 1985 (MMWR 1985;34:373-75) and 1987
(MMWR 1987;36[suppl no. 1S]:1S-15S). The case
definition for adults and adolescents was modified
again in 1993 (MMWR 1992;41[no. RR-17]:1-19; see
also MMWR 1995;44:64-67). The revisions incorpo-
rated a broader range of AIDS-indicator diseases and
conditions and used HIV diagnostic tests to improve
the sensitivity and specificity of the definition. The lab-
oratory and diagnostic criteria for the 1987 pediatric
case definition (MMWR 1987;36:225-30, 235) were
updated in 1994 (MMWR  1994;43[no. RR-12]: 1-19).
For persons with laboratory-confirmed HIV infec-
tion, the 1987 revision incorporated HIV encephalop-
athy, wasting syndrome, and other indicator diseases
that are diagnosed presumptively (i.e., without confir-
matory laboratory evidence of the opportunistic dis-
ease). In addition to the 23 clinical conditions in the
1987 definition, the 1993 case definition for adults and
adolescents includes HIV-infected persons with CD4+
T-lymphocyte counts of less than 200 cells/µL or a
CD4+ percentage of less than 14, and persons diag-
nosed with pulmonary tuberculosis, recurrent pneu-
monia, and invasive cervical cancer. All conditions
added to the 1993 definition require laboratory confir-
mation of HIV infection. Persons who meet the criteria
for more than one definition category are classified hi-
erarchically in the following order: pre-1987, 1987,
and 1993. Persons in the 1993 definition category
meet only the 1993 definition. 
The pediatric case definition incorporates the re-
vised 1994 pediatric classification system for evi-
dence of HIV infection. Children with their first positive
results on Western blot or HIV detection tests before
October 1994 were categorized based on the 1987
classification system. Those tested during or after Oc-
tober 1994 are categorized under the revised 1994
pediatric classification system. For children of any age
1Included among the dependencies, possessions, and independent
nations are Puerto Rico, the U.S. Virgin Islands, Guam, American
Samoa, the Republic of Palau, the Republic of the Marshall Islands, the
Commonwealth of the Northern Mariana Islands, and the Federated
States of Micronesia. The latter 5 comprise the category “Pacific Islands,
U.S.” listed in tables 1 and 28.
with an AIDS-defining condition that requires evi-
dence of HIV infection, a single positive HIV-detection
test (i.e., HIV culture, HIV PCR, or HIV antigen [p24])
is sufficient for a reportable AIDS diagnosis if the diag-
nosis is confirmed by a physician. The 1994 pediatric
definitions for HIV encephalopathy and HIV wasting
syndrome reflect increased knowledge of these condi-
tions in children, and replace the 1987 definitions.
Although completeness of reporting of diagnosed
AIDS cases to state and local health departments var-
ies by geographic region and patient population, stud-
ies conducted by state and local health departments
indicate that reporting of AIDS cases in most areas of
the United States is more than 85 percent complete (J
Acquir Immune Def Syndr, 1992;5:257-64 and Am J
Public Health 1992;82:1495-99). In addition, multiple
routes of exposure, opportunistic diseases diagnosed
after the initial AIDS case report was submitted to
CDC, and vital status may not be determined or re-
ported for all cases. However, among persons report-
ed with AIDS, reporting of deaths is estimated to be
more than 90 percent complete (JAMA 1996;276:126-
31).
Included in this report are persons known to be in-
fected with human immunodeficiency virus type 2
(HIV-2). See MMWR 1995;44:603-06.
Surveillance of HIV infection
Through June 30, 1997, 26 states had laws or reg-
ulations requiring confidential reporting by name of all
persons with confirmed HIV infection, in addition to re-
porting of persons with AIDS. Two other states, Con-
necticut and Texas, required reporting by name of HIV
infection only for children less than 13 years of age;
and Oregon required reporting for children less than 6
years of age. These states initiated reporting at vari-
ous times after the development of serum HIV-anti-
body tests in 1985. Before 1991, surveillance of HIV
infection was not standardized and reporting of HIV in-
fections was based primarily on passive surveillance.
Consequently, many cases reported before 1991 do
not have complete information. Since then, CDC has
assisted states in conducting active surveillance of
HIV infection using standardized report forms and
software. However, collection of demographic and
risk information still varies among states. 
Estimates of the prevalence of HIV infection in the
United States in 1992 were between 650,000 and
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900,000 (JAMA 1996;276:126-31). However, HIV sur-
veillance reports are not representative of all persons
estimated to be infected with HIV; HIV infection data
should be interpreted with caution. Because many
HIV-reporting states also offer anonymous HIV test-
ing, confidential HIV infection reports are not repre-
sentative of all persons being tested in these areas.
Furthermore, many factors may influence testing pat-
terns, including the extent that testing is targeted or
routinely offered to specific groups and the availability
and access to medical care and testing services.
These data provide a minimum estimate of the num-
ber of persons known to be HIV infected in states with
confidential HIV infection reporting.
For this report, persons greater than 18 months of
age were considered HIV infected if they had at least
one positive Western blot or positive detection test
(culture, antigen, or other detection test) or had a di-
agnosis of HIV infection documented by a physician.
Before October 1994, children less than 15 months of
age were considered HIV infected if they met the def-
inition stated in the 1987 pediatric classification sys-
tem for HIV infection (MMWR 1987;36:225-30, 235).
Beginning October 1994, children less than 18
months of age are considered HIV infected if they
meet the definition stated in the 1994 pediatric classi-
fication system for HIV infection (MMWR 1994;43[no.
RR-12]:1-10). This report also includes children who
were diagnosed by a physician as HIV infected. Al-
though many states monitor reports of children born to
infected mothers, only those with documented diag-
nosis of HIV infection are included in this report. 
Because states initiated reporting on different
dates, the length of time reporting has been in place
will influence the number of HIV infection cases re-
ported. For example, data presented for a given annu-
al period may include cases reported during only a
portion of the year. Prior to statewide HIV reporting,
some states collected reports of HIV infection in se-
lected populations. Therefore, these states have re-
ports prior to initiation of statewide confidential
reporting.
Over time, persons with HIV infection will be diag-
nosed and reported with AIDS. HIV infection cases
later reported with AIDS are deleted from the HIV in-
fection tables and added to the AIDS tables. Persons
with HIV infection may be tested at any point in the
clinical spectrum of disease; therefore, the time be-
tween diagnosis of HIV infection and AIDS will vary. In
addition, because surveillance practices differ, report-
ing and updating of clinical and vital status of cases
vary among states. 
Included in this report are persons known to be in-
fected with human immunodeficiency virus type 2
(HIV-2). See MMWR 1995;44:603-06.
Tabulation and presentation of data
Data in this report are provisional. Each issue of this
report includes information received by CDC through
the last day of the reporting period. AIDS data are tab-
ulated by date of report to CDC unless otherwise not-
ed. Data for U.S. dependencies and possessions and
for associated independent nations are included in the
totals. 
Age group tabulations are based on the person’s
age at first documented positive HIV-antibody test re-
sult for HIV infection cases, and age at diagnosis of
AIDS for AIDS cases. Adult/adolescent cases include
persons 13 years of age and older; pediatric cases in-
clude children under 13 years of age. Age group tab-
ulations for AIDS cases in table 14 (year-end edition
only) are based on age at death.
Tabulations of persons living with HIV infection and
AIDS (table 28), include persons whose vital status
was “alive” as of the last update; persons whose vital
status is missing or unknown are not included. Tabu-
lations of deaths in persons with AIDS include per-
sons whose vital status was “dead” as of the last
update; persons whose vital status is missing or un-
known are not included. Caution should be used in in-
terpreting these data because states vary in the
frequency with which they review the vital status of
persons reported with HIV infection and AIDS. In ad-
dition, some cases may be lost to follow-up.
Table 12 (year-end edition only) tabulates AIDS-in-
dicator conditions reported during the last year. These
data are known to underreport AIDS-indicator condi-
tions and should be interpreted with caution. Reported
conditions overrepresent initial AIDS-indicator illness
because follow-up for subsequent indicator diseases
is resource intensive and has not been systematic or
standardized in most health departments. The 1993
AIDS surveillance case definition for adults and ado-
lescents added reporting of HIV-infected persons with
severe HIV-related immunosuppression (CD4+ T-lym-
phocyte count of less than 200/µL or less than 14 per-
cent). Since implementation of the 1993 definition,
reporting of AIDS cases based on AIDS-defining op-
portunistic infections has decreased (AIDS 1994;
8:1489-93).
Table 2 lists AIDS case counts for each metropoli-
tan area with an estimated 1996 population of
500,000 or more. AIDS case counts for metropolitan
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areas with 50,000 to 500,000 population are reported
as a combined subtotal. On December 31, 1992, the
Office of Management and Budget announced new
Metropolitan Statistical Area (MSA) definitions, which
reflect changes in the U.S. population as determined
by the 1990 census. These definitions were updated
most recently on July 1, 1996. The cities and counties
which compose each metropolitan area listed in table
2 are provided in the publication “Metropolitan Areas
as of June 30, 1995” (available by calling the National
Technical Information Service, 1–703–487–4650, and
ordering accession no. PB95-208880). Standards for
defining central and outlying counties of metropolitan
areas were published in the Federal Register (FR
1990;55:12154-60).
The metropolitan area definitions are the MSAs for
all areas except the 6 New England states. For these
states, the New England County Metropolitan Areas
(NECMA) are used. Metropolitan areas are named for
a central city in the MSA or NECMA, may include sev-
eral cities and counties, and may cross state bound-
aries. For example, AIDS cases and annual rates
presented for the District of Columbia in table 1 in-
clude only persons residing within the geographic
boundaries of the District. AIDS cases and annual
rates for Washington, D.C., in table 2 include persons
residing within the several counties in the metropolitan
area, including counties in Maryland, Virginia, and
West Virginia. State or metropolitan area data tabula-
tions are based on the person’s residence at first pos-
itive HIV-antibody test result for HIV infection cases
and residence at diagnosis of the first AIDS-indicator
condition(s) for AIDS cases.  
Estimates of AIDS-opportunistic illness (AIDS-OI)
incidence (tables 13, 14, and 15), estimated deaths
(tables 16, 17, and 18), and estimated persons living
with AIDS (tables 19, 20, and 21) are not counts of ac-
tual numbers of persons reported to the surveillance
system.  The estimates are adjusted for delays in re-
porting of cases and deaths and are based on a num-
ber of assumptions (for example, see “Estimated
AIDS-opportunistic illness” infra).  While these tables
use the best estimates currently available, there is in-
herent uncertainty in these estimates.  Therefore, the
estimates in this report are rounded.  Other analyses
(J.M. Karon, Estimating the number of AIDS-defining
opportunistic illness diagnoses from data collected
under the 1993 AIDS surveillance definition, J Acquir
Immune Def Syndr, in press) suggest that the uncer-
tainty in these estimates is at least one percent.
Therefore, the rounding is to one percent of the upper
limit within arbitrarily chosen ranges.  State and local
surveillance staff are encouraged to adopt similar
rounding conventions when presenting estimates.  As
is standard computational practice, changes in the es-
timates of the AIDS-OI incidence, estimates of deaths,
and estimates of persons living with AIDS should be
computed from unrounded numbers, rather than from
rounded numbers.  That is, an estimate, such as the
percent change in annual incidence, should not be
computed from the rounded estimates of AIDS-OI in-
cidence.  An estimate of change computed from
rounded numbers is especially unreliable if the annual
estimates are relatively small.
Exposure categories
For surveillance purposes, HIV infection cases and
AIDS cases are counted only once in a hierarchy of
exposure categories. Persons with more than one re-
ported mode of exposure to HIV are classified in the
exposure category listed first in the hierarchy, except
for men with both a history of sexual contact with other
men and injecting drug use. They make up a separate
exposure category. 
“Men who have sex with men” cases include men
who report sexual contact with other men (i.e., homo-
sexual contact) and men who report sexual contact
with both men and women (i.e., bisexual contact).
“Heterosexual contact” cases are in persons who re-
port specific heterosexual contact with a person with,
or at increased risk for, HIV infection (e.g., an injecting
drug user).
Adults/adolescents born, or who had sex with
someone born, in a country where heterosexual trans-
mission was believed to be the predominant mode of
HIV transmission (formerly classified as Pattern-II
countries by the World Health Organization) are no
longer classified as having heterosexually acquired
AIDS. Similar to case reports for other persons who
are reported without behavioral or transfusion risks for
HIV, these reports are now classified (in the absence
of other risk information which would classify them
into another exposure category) as “no risk reported
or identified” (MMWR 1994;43:155-60). Children
whose mother was born, or whose mother had sex
with someone born, in a Pattern-II country are now
classified (in the absence of other risk information
which would classify them into another exposure cat-
egory) as “Mother with/at risk for HIV infection: has
HIV infection, risk not specified.”
“No risk reported or identified” cases are in persons
with no reported history of exposure to HIV through
any of the routes listed in the hierarchy of exposure
categories. Risk not identified cases include persons
who are currently under investigation by local health
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department officials; persons whose exposure history
is incomplete because they died, declined to be inter-
viewed, or were lost to follow-up; and persons who
were interviewed or for whom other follow-up informa-
tion was available and no exposure mode was identi-
fied. Persons who have an exposure mode identified
at the time of follow-up are reclassified into the appro-
priate exposure category. In general, investigations
and follow up for modes of exposure by state health
departments are conducted routinely for persons re-
ported with AIDS and as resources allow for those re-
ported with HIV infection. Therefore, the percentage
of HIV infected persons with risk not reported or iden-
tified is substantially higher than for those reported
with AIDS. As HIV infected persons with risk not re-
ported or identified are diagnosed and reported with
AIDS, they are assigned higher priority for follow-up to
determine the mode(s) of exposure.
Estimated AIDS-opportunistic illness
In 1993, the AIDS surveillance case definition was
expanded to include a laboratory measure of severe
immunosuppression (CD4+ T-lymphocyte count of
less than 200 cells/µL or a percent of total lympho-
cytes less than 14) and three additional clinical condi-
tions (pulmonary tuberculosis, recurrent pneumonia,
and invasive cervical cancer). Before 1993, the sur-
veillance definition included only opportunistic illness-
es, and trends in the incidence of AIDS were
evaluated by examining the number of AIDS opportu-
nistic illnesses (AIDS-OIs) diagnosed per year or
quarter, adjusted for reporting delays. Because most
HIV-infected persons become severely immunosup-
pressed before the onset of AIDS-OIs, the addition of
the CD4+ criteria has temporarily distorted observed
trends in AIDS incidence. To examine trends over
time, additional adjustments are required to estimate
when an AIDS-OI will develop in persons who were
reported based on the CD4+ criteria. CDC has devel-
oped a procedure to estimate the incidence of AIDS-
OIs among persons reported with AIDS based on the
CD4+ criteria. Estimates of trends in AIDS-OIs are dis-
played in tables 13, 14, and 15. Annual estimates are
through the most recent year for which reliable esti-
mates are available. 
The estimated AIDS-OI incidence is the sum of in-
cidence in two groups.  Cases in both groups are ad-
justed for delays in case reporting  The first group is
persons reported to AIDS surveillance with AIDS-OIs.
The second group is persons reported with AIDS
based on a CD4+ count or percent. Most of these per-
sons will eventually have an AIDS-OI diagnosed. CDC
has estimated the number of persons who had or will
have an AIDS-OI diagnosed after the date of the re-
ported CD4+ count or percent, by month of AIDS-OI
diagnosis. To do this, CDC used data from the Adult
Spectrum of Disease Project (JAMA 1992; 267:1798-
1805) to estimate the probability distribution of the
time interval between a CD4+ count in a particular
range (e.g., 0 to 29 cells/µL, 30 to 59 cells/µL, etc.)
and the diagnosis of an AIDS-OI, taking into account
the possibility of death before an AIDS-OI diagnosis.
This probability distribution is the proportion of per-
sons with a CD4+ count in a given range who will have
an AIDS-OI diagnosed 1 month, 2 months, etc., after
the reported CD4+ count. The expected number of
persons with an AIDS-OI diagnosed in each later
month among persons whose CD4+ count was in a
particular range during a given month is the product of
the number of these persons and the proportion ex-
pected to have an AIDS-OI diagnosed in this later
month. The estimate of the number of AIDS-OI diag-
noses in a particular month among persons reported
with AIDS based on the CD4+ criteria is the sum, over
all combinations of CD4+ ranges and previous
months, of the number of persons expected to be di-
agnosed with an AIDS-OI in the month for which the
estimate is made.
There is uncertainty in these estimates of AIDS-OI
incidence. Some uncertainty is the result of the need
to adjust for delays in reporting of AIDS cases. Other
persons reported with AIDS based on the CD4+ cri-
teria have an unreported AIDS-OI diagnosis by the
date of the CD4+ determination; the estimation proce-
dure counts their contribution to AIDS-OI incidence
later than it should. However, preliminary analyses
show that this source of bias changes estimated
AIDS-OI incidence by only a few percentage points.
Recently reported AIDS cases are more likely to be
reported with risk not reported or identified (NIR). Re-
cent AIDS incidence in some exposure categories,
therefore, will be underestimated unless an adjust-
ment is made. The adjustment of NIR adult/adoles-
cent cases is based on the sex-, race-, and region-
specific exposure category redistributions of cases di-
agnosed from 1989 through 1995 that were initially
assigned to the NIR category but have subsequently
been reclassified.  Similar adjustment of NIR pediatric
cases are based on exposure category redistribution
of all cases diagnosed between 1989 through 1995
and subsequently reclassified.  See J Acquir Immune
Def Syndr, 1992;5:547-55 and J Acquir Immune Def
Syndr, 1997;14:465-74. 
The regions of residence included in table 13, 16,
and 19 are defined as follows. Northeast: Connecticut,
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Maine, Massachusetts, New Hampshire, New Jersey,
New York, Pennsylvania, Rhode Island, and Vermont;
Midwest: Indiana, Illinois, Iowa, Kansas, Michigan,
Minnesota, Missouri, Nebraska, North Dakota, Ohio,
South Dakota, and Wisconsin; South: Alabama, Ar-
kansas, Delaware, District of Columbia, Florida, Geor-
gia, Kentucky, Louisiana, Maryland, Mississippi,
North Carolina, Oklahoma, South Carolina, Tennes-
see, Texas, Virginia, and West Virginia; West: Alaska,
Arizona, California, Colorado, Idaho, Hawaii, Mon-
tana, Nevada, New Mexico, Oregon, Utah, Washing-
ton, and Wyoming; Territories: Guam, Puerto Rico,
the U.S. Virgin Islands, and the U.S. Pacific Islands
listed on page 33.
Reporting delays
Reporting delays (time between diagnosis of HIV
infection or AIDS and report to CDC) may vary among
exposure, geographic, racial/ethnic, age and sex cat-
egories, and have been as long as several years for
some AIDS cases. About 50 percent of all AIDS cases
were reported to CDC within 3 months of diagnosis,
with about 20 percent being reported more than 1 year
after diagnosis. Among persons with AIDS, estimates
in delay of reporting of deaths show that approximate-
ly 80 percent of deaths are reported within 1 year. Re-
porting delay for HIV infection cases is being
evaluated. 
Reporting delay adjustments to tables 13 through
21 were estimated by a maximum likelihood statistical
procedure, taking into account differences in reporting
delays among exposure, geographic, racial/ethnic,
age, sex, and vital status at diagnosis categories, but
assuming that reporting delays within these groups
have not changed over time (Lecture Notes in Biom-
athematics 1989;83:58-88).
Rates
Rates are calculated for 12-month period per
100,000 population for AIDS cases only. Rates are
not calculated for HIV infection reports because case
counts for HIV infection are believed to be less com-
plete than AIDS case counts. Population denomina-
tors for computing AIDS rates for the 50 states and the
District of Columbia are based on official postcensus
estimates from the U.S. Bureau of Census. Denomi-
nators for U.S. dependencies and possessions and
associated independent nations are linear extrapola-
tions of official 1980 and 1990 census counts.   Each
12-month rate is the number of cases reported during
the 12-month period, divided by the 1995 or 1996 pop-
ulation, multiplied by 100,000.   The denominators for
computing race-specific rates (table 10, year-end edi-
tion only) are based on 1996 census estimates pub-
lished in U.S. Bureau of Census publication PE-
101PL-57, “U.S. Population Estimates by Age, Sex,
Race, and Hispanic Origin: 1990 to 1996.”  Race-spe-
cific rates are the number of cases reported for a par-
ticular racial/ethnic group during the preceding 12-
month period divided by the projected population for
that race/ethnicity, multiplied by 100,000.
Case-fatality rates are calculated for each half-year
by date of diagnosis of AIDS. Each 6-month case-fa-
tality rate is the number of deaths ever reported
among cases diagnosed in that period (regardless of
the year of death), divided by the number of total cas-
es diagnosed in that period, multiplied by 100. Report-
ed deaths are not necessarily caused by HIV-related
disease. Caution should be used in interpreting case-
fatality rates because reporting of deaths is incom-
plete (Am J Public Health 1992;82:1500-05 and Am J
Public Health 1990;80:1080-86).
